Scolaris Content Display Scolaris Content Display

Workplace interventions for smoking cessation

Esta versión no es la más reciente

Contraer todo Desplegar todo

Referencias

References to studies included in this review

Burling 1989 {published data only}

Burling TA, Marotta J, Gonzalez R, Moltzen JO, Eng AM, Schmidt GA, et al. Computerized smoking cessation program for the worksite: treatment outcome and feasibility. Journal of Consulting and Clinical Psychology 1989;57:619‐622.

Burling 2000 {published data only}

Burling AS, Burling TA. A work in progress: Effectiveness of a comprehensive internet‐delivered interactive multimedia stop smoking program. Presented at the 34th Annual Convention of the Association for the Advancement of Behavior Therapy, New Orleans, LA, November 2000.

Cambien 1981 {published data only}

Cambien F, Richard JL, Ducimetiere P, Warnet JM, Kahn J. The Paris Cardiovascular Risk Factor Prevention Trial: Effects of two years of intervention in a population of young men. Journal of Epidemiology and Community Health 1981;35:91‐7.

Campbell 2002 {published data only}

Campbell MK, Tessaro I, DeVellis B, Benedict S, Kelsey K, Belton L, et al. Effects of a tailored health promotion program for female blue‐collar workers: Health Works for Women. Preventive Medicine 2002;34:313‐23.
Tessaro I, Campbell MK, Benedict S, Kelsey K, Heisler‐MacKinnon J, Belton L, et al. Developing a worksite health promotion intervention: Health Works for Women. American Journal of Health Behavior 1998;22(6):434‐42.
Tessaro I, Taylor S, Belton L, Campbell MK, Benedict S, Kelsey K, et al. Adapting a natural (lay) helpers model of change for worksite health promotion for women. Health Education Research 2000;15(5):603‐14.

Dawley 1991 {published data only}

Dawley HH, Dawley LT, Correa P, Fleischer B. A comprehensive worksite smoking control, discouragement, and cessation program. International Journal of Addiction 1991;26:685‐696.

DePaul 1987 {published data only}

Flay BR, Gruder CL, Warnecke RB, Jason LA, Peterson P. One year follow‐up of the Chicago televised smoking cessation program. American Journal of Public Health 1989;79:1377‐80. [MEDLINE: 1989390780]
Jason LA, Gruder CL, Buckenberger L, Lesowitz T, Belgredan J, Flay BR, Warnecke RB. A 12‐month follow‐up of a worksite smoking cessation intervention. Health Education Research 1987;2:185‐94.
Jason LA, Gruder CL, Martino S, Flay BR. Work site group meetings and the effectiveness of a televised smoking cessation intervention. American Journal of Community Psychology 1987;15:57‐72. [MEDLINE: 1987267430]

DePaul 1989 {published data only}

Jason LA, Lesowitz T, Michaels M, Blitz C, Victors L, Dean L, et al. A Worksite Smoking Cessation Intervention Involving the Media and Incentives. American Journal of Community Psychology 1989;17:785‐99. [MEDLINE: 199261661]
Salina D, Jason LA, Hedeker D, Kaufman J, Lesondak L, McMahon SD, et al. A follow‐up of a media‐based, worksite smoking cessation program. Amercian Journal of Community Psychology 1994;22:257‐71. [MEDLINE: 1995067774]

DePaul 1994 {published data only}

Jason LA, McMahon SD, Salina D, Hedeker D, Stockton M, Dunson K, et al. Assessing a smoking cessation intervention involving groups, incentives, and self‐help manuals. Behavior Therapy 1995;26:393‐408.
Jason LA, Salina D, McMahon SD, Hedeker D, Stockton M. A worksite smoking intervention: A 2 year assessment of groups, incentives and self‐help. Health Education Research 1997;12:129‐38.
McMahon SD, Jason LA, Salina D. Stress, coping, and appraisal in a smoking cessation intervention. Anxiety, Stress and Coping 1994;7(2):161‐71.

Emmons 1999 {published data only}

Emmons KM, Linnan LA, Shadel WG, Marcus B, Abrams DB. The Working Healthy Project: a worksite health‐promotion trial targeting physical activity, diet, and smoking. Journal of Occupational and Environmental Medicine 1999;41(7):545‐55.

Erfurt 1991 {published data only}

Erfurt JC, Foote A, Heirich MA. The cost‐effectiveness of work‐site wellness programs for hypertension control, weight loss, and smoking cessation. Journal of Occupational Medicine 1991;33:962‐70.
Erfurt JC, Foote A, Heirich MA. Worksite wellness programs: Incremental comparison of screening and referral alone, health education, follow‐up counselling, and plant organization. American Journal of Health Promotion 1991;5:438‐449.
Gregg W, Foote A, Erfurt JC, Heirich MA. Worksite follow‐up and engagement strategies for initiating health risk behavior changes. Health Education Quarterly 1990;17:455‐78.

Frank 1986 {published data only}

Frank RG, Umlauf RL, Wonderlich SA, Ashkanazi GS. Hypnosis and behavioral treatment in a worksite smoking cessation program. Addictive Behaviors 1986;11(1):59‐62.

Glasgow 1984 {published data only}

Glasgow RE, Klesges RC, Godding PR, Vasey MW, O'Neill HK. Evaluation of a worksite‐controlled smoking program. Journal of Consulting and Clinical Psychology 1984;52(1):137‐138.

Glasgow 1986 {published data only}

Glasgow RE, Klesges RC, O'Neill HK. Programming social support for smoking modification: an extension and replication. Addictive Behaviors 1986;11:453‐457.

Glasgow 1993 {published data only}

Glasgow RE, Hollis JF, Ary DV, Boles SM. Results of a year‐long incentives‐based worksite smoking‐cessation program. Addictive Behaviors 1993;18:455‐464.
Glasgow RE, Hollis JF, Ary DV, Lando HA. Employee and organizational factors associated with participation in an incentive‐based worksite smoking cessation program. Journal of Behavioral Medicine 1990;13(4):403‐18.
Glasgow RE, Hollis JF, Pettigrew L, Foster L, Givi MJ, Morrisette G. Implementing a year‐long worksite‐based incentive program for smoking cessation. American Journal of Health Promotion 1991;5(3):192‐9.

Glasgow 1995 {published data only}

Glasgow RE, Terborg JR, Hollis JF, Severson HH, Boles SM. Take Heart: Results from the initial phase of a work‐site wellness program. American Journal of Public Health 1995;85:209‐216.
Glasgow RE, Terborg JR, Hollis JF, Severson HH, Fisher KJ, Boles SM, et al. Modifying dietary and tobacco use patterns in the worksite: the Take Heart Project. Health Education Quarterly 1994;21:69‐82.

Gomel 1993a {published data only}

Gomel M, Oldenburg B, Simpson JM, Chilvers M, Owen N. Composite cardiovascular risk outcomes of a work‐site intervention trial. American Journal of Public Health 1997;87(4):673‐6.
Gomel M, Oldenburg B, Simpson JM, Owen N. Work‐site cardiovascular risk reduction: a randomized trial of health risk assessment, education, counseling, and incentives. American Journal of Public Health 1993;83(9):1231‐8.

Gunes 2007 {published data only}

Gunes G, Ilgar M, Karaoglu L. The effectiveness of an education program on stages of smoking behavior for workers at a factory in Turkey. Industrial Health 2007;45:232‐6.

Hennrikus 2002 {published data only}

Hennrikus DJ, Jeffery RW, Lando HA, Murray DM, Brelje K, Davidann B, et al. The SUCCESS project: the effect of program format and incentives on participation and cessation in worksite smoking cessation programs. American Journal of Public Health 2002;92(2):274‐279.
Martinson BC. Intraclass correlation for measures from a worksite health promotion study: estimates, correlates, and applications. American Journal of Health Promotion 2000;14(4):271.
Martinson BC, Murray DM, Jeffery RW, Hennrikus DJ. Intraclass correlation for measures from a worksite health promotion study: Estimates, correlates, and applications. American Journal of Health Promotion 1999;13:347‐57.

Hymowitz 1991 {published data only}

Hymowitz N, Campbell K, Feuerman M. Long‐term smoking intervention at the worksite: effects of quit‐ smoking groups and an "enriched milieu" on smoking cessation in adult white‐collar employees. Health Psychology 1991;10(5):366‐69.

Jeffery 1988 {published data only}

Jeffery RW, Pheley AM, Forster JL, Kramer FM, Snell MK. Payroll contracting for smoking cessation: a worksite pilot study. American Journal of Preventive Medicine 1988;4:83‐86.

Kadowaki 2000 {published data only}

Kadowaki T, Kanda H, Watanabe M, Okayama A, Miyamatsu N, Okamura T, et al. Are comprehensive environmental changes as effective as health education for smoking cessation?. Tobacco Control 2006;15(1):26‐9.
Kadowaki T, Watanabe M, Okayama A, Hishida K, Ueshima H. Effectiveness of smoking‐cessation intervention in all of the smokers at a worksite in Japan. Industrial Health 2000;38(4):396‐403.

Klesges 1987 {published data only}

Klesges R, Glasgow RE, Klesges L, et al. Competition and relapse prevention training in worksite smoking modification. Health Education Research 1987;2:5‐14.

Kornitzer 1980 {published data only}

De Backer G, Kornitzer M, Dramaix M, Kittel F, Thilly C, Graffar M, et al. The Belgian Heart Disease Prevention Project: 10‐year mortality follow‐up. European Heart Journal 1988;9:238‐42.
De Backer G, Kornitzer M, Thilly C, Depoorter AM. The Belgian multifactor preventive trial in CVD (I): design and methodology. Hart Bulletin 1977;8:143‐6.
Kornitzer M. The Belgian Heart Disease Prevention Project: a model of multifactorial prevention [Le projet Belge de prevention des affections cardiovasculaires: un modele de prevention multifactorielle]. Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 1989;144:101‐9.
Kornitzer M, De Backer G, Dramaix M. The Belgian Heart Disease Prevention Project: modification of the coronary risk profile in an industrial population. Circulation 1980;61(1):18‐25.
Kornitzer M, Dramaix M, De Backer G, Thilly C. The Belgian multifactor preventive trial in CVD (III): smoking habits and sociobiological variables. Hart Bulletin 1978;1:7‐13.
Kornitzer M, Dramaix M, Kittel F, De Backer G. The Belgian Heart Disease Prevention Project: changes in smoking habits after two years of intervention. Preventive Medicine 1980;9:496‐503.
Kornitzer M, Dramaix M, Thilly C, De Backer G, Kittel F, Graffar M, et al. Belgian Heart Disease Prevention Project: incidence and mortality results. The Lancet 1983;321(8333):1066‐70.
Kornitzer M, Rose G. WHO European Collaborative Trial of multifactorial prevention of coronary heart disease. Preventive Medicine 1985;14:272‐8.
Rustin R‐M, Kittel F, Dramaix M, Kornitzer M, De Backer G. Smoking habits and psycho‐socio‐biological factors. Journal of Psychosomatic Research 1978;22:89‐99.

Kornitzer 1987 {published data only}

Kornitzer M, Kittel F, Dramaix M, Bourdoux P. A double blind study of 2 mg versus 4 mg nicotine‐gum in an industrial setting. Journal of Psychosomatic Research 1987;31(2):171‐176.

Kornitzer 1995 {published data only}

Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. Combined use of nicotine patch and gum in smoking cessation: a placebo‐controlled clinical‐trial. Preventive Medicine 1995;24:41‐47.

Lang 2000 {published data only}

Lang T, Nicaud V, Slama K, Hirsch A, Imbernon E, Goldberg M, et al. Smoking cessation at the workplace. Results of a randomised controlled intervention study. Worksite physicians from the AIREL group. Journal of Epidemiology and Community Health 2000;54:349‐354.

Li 1984 {published data only}

Li VC, Kim YJ, Ewart CK. Effects of physician counseling on the smoking behavior of asbestos‐exposed workers. Preventive Medicine 1984;13:462‐476.

Malott 1984 {published data only}

Malott JM, Glasgow RE, O'Neill HK, Klesges RC. Co‐worker social support in a worksite smoking control program. Journal of Applied Behavior Analysis 1984;17(4):485‐495.

Nilsson 2001 {published data only}

Nilsson PM, Klasson E‐B, Nyberg P. Lifestyle intervention at the worksite ‐ reduction of cardiovascular factors in a randomized study. Scandinavian Journal of Work and Environmental Health 2001;27(1):57‐62.

Omenn 1988 {published data only}

Curry S, Thompson B, Sexton M, Omenn GS. Psychosocial predictors of outcome in a worksite smoking cessation program. Amercian Journal of Preventive Medicine 1989;5:2‐7.
Omenn GS, Thompson B, Sexton MJ, Hessol N, Breitenstein B, Curry SJ, Michnich M, Peterson A. A randomized comparison of worksite‐sponsored smoking cessation programs. American Journal of Preventive Medicine 1988;4(5):261‐267.
Thompson B, Omenn G, Sexton M, Breitenstein B, Hessol N, Curry S, et al. Worksite smoking cessation: a test of two programs. Progress in Clinical and Biological Research 1987;248:93‐100.

Rand 1989 {published data only}

Rand CS, Stitzer ML, Bigelow GE, Mead AM. The effects of contingent payment and frequent workplace monitoring on smoking abstinence. Addictive Behaviors 1989;14:121‐8.

Razavi 1999 {published data only}

Razavi D, Vandecasteele H, Primo C, Bodo M, Debrier F, Verbist H, et al. Maintaining abstinence from cigarette smoking: effectiveness of group counselling and factors predicting outcome. European Journal of Cancer 1999;35(8):1238‐1247.

Rodriguez 2003 {published data only (unpublished sought but not used)}

Guallar‐Castillon P, Lafuente Urdinguio P, Garteizaurrekoa Dublang P, Sainz Martinez O, Diez Azcarate JI, Foj Aleman M, et al. Probability of success in tobacco quitting during the course of two simple medical interventions [Probabilidad de exito en el abandono del tabaco en el curso de dos intervenciones sencillas para dejar de fumar]. Revista Espanol de Salud Publica 2003;77(1):117‐24.
Rodriguez‐Artalejo F, Lafuente Urdinguio P, Guallar‐Castillon P, Garteizaurrekoa Dublang P, Sainz Martinez O, Diez Azcarate JI, et al. One year effectiveness of an individualised smoking cessation intervention at the workplace: a randomised controlled trial. Occupational Environmental Medicine 2003;60(3):358‐63.

Schröter 2006 {published data only}

Schröter M, Collins SE, Frittrang T, Buchkremer G, Batra A. Randomized controlled trial of relapse prevention and a standard behavioral intervention with adult smokers. Addictive Behaviors 2006;31:1259‐64.

Shi 1992 {published data only}

Shi L. The impact of increasing intensity of health promotion intervention on risk reduction. Evaluation and the Health Professions 1992;15(4):3‐25.

Shimizu 1999 {published data only}

Shimizu J, Kita Y, Kai K, Okayama A, Choudhury SR, Kawashima J, et al. Randomized controlled trial for smoking cessation among city office employees. Nippon Koshu Eisei Zasshi 1999;46(1):3‐13.

Sorensen 1993 {published data only}

Sorensen G, Lando HA, Pechacek TF. Promoting smoking cessation at the workplace. Results of a randomized controlled intervention study. Journal of Occupational Medicine 1993;35(2):121‐126.

Sorensen 1996 {published data only}

Biener L, Glanz K, McLerran D, Sorensen G, Thompson B, BasenEngquist K, et al. Impact of the Working Well Trial on the worksite smoking and nutrition environment. Health Education Behavior 1999;26:478‐94.
Callaghan RC, Herzog TA. The relation between processes‐of‐change and stages‐transition in smoking behavior: a two‐year longitudinal study of the Transtheoretical Model. Addictive Behaviors 2006;31:1331‐45.
Emmons KM, Marcus BH, Linnan L, Rossi JS, Abrams DB. Mechanisms in multiple risk factor interventions: smoking, physical activity, and dietary fat intake among manufacturing workers. Working Well Research Group. Preventive Medicine 1994;23(4):481‐9.
Emmons KM, Thompson B, McLerran D, Sorensen G, Linnan L, Basen‐Engquist K, et al. The relationship between organizational characteristics and the adoption of workplace smoking policies. Health Education and Behavior 2000;27(4):483‐501.
Sorensen G, Thompson B, Basen‐Engquist K, Abrams D, Kuniyuki A, DiClemente C, et al. Durability, dissemination, and institutionalization of worksite tobacco control programs: Results from the Working Well trial. International Journal of Behavioural Medicine 1998;5(4):335‐351.
Sorensen G, Thompson B, Glanz K, Feng Z, Kinne S, DiClemente C, et al. Work site‐based cancer prevention: primary results from the Working Well Trial. Amercian Journal of Public Health 1996;86(7):939‐947.
Wetter DW, Cofta‐Gunn L, Fouladi RT, Irvin JE, Daza P, Mazas C, et al. Understanding the associations among education, employment characteristics, and smoking. Addictive Behaviors 2005;30(5):905‐14.
Wetter DW, McClure JB, de Moor C, Cofta‐Gunn L, Cummings S, Cinciripini PM, et al. Concomitant use of cigarettes and smokeless tobacco: prevalence, correlates, and predictors of tobacco cessation. Preventive Medicine 2002;34(6):638‐48.

Sorensen 1998 {published data only}

Sorensen G, Himmelstein J, Hunt M, Youngstrom R, Hebert J, Hammond S, et al. A model for worksite cancer prevention: integration of health protection and health promotion in the WellWorks Project. American Journal of Health Promotion 1995;10:55‐62.
Sorensen G, Stoddard A, Hammond S, Hebert J, Ockene J. Double jeopardy: job and personal risks for cratfspersons and laborers. American Journal of Health Promotion 1996;10:355‐363.
Sorensen G, Stoddard A, Hunt MK, Herbert JR, Ockene JK, Avrunin JS, et al. The effects of a health promotion‐health protection intervention on behavior change: the WellWorks study. American Journal of Public Health 1998;88(11):1685‐1690.
Sorensen G, Stoddard A, Ockene JK, Hunt MK, Youngstrom R. Worker participation in an integrated health promotion/health protection program: Results from the WellWorks Project. Health Education Quarterly 1996;23(2):191‐203.

Sorensen 2002 {published data only}

Hunt MK, Lederman R, Stoddard AM, LaMontagne AD, McLellan D, Combe C, et al. process evaluation of an integrated health promotion/occupational health model in WellWorks‐2. Health Education and Behavior 2005;32(1):10‐26.
Sorensen G, Stoddard AM, LaMontagne AD, Emmons K, Hunt MK, Youngstrom R, et al. A comprehensive worksite cancer prevention intervention: behavior change results from a randomized controlled trial (United States). Cancer Causes and Control 2002;13:493‐502.
Sorensen G, Stoddard AM, LaMontagne AD, Emmons K, Hunt MK, Youngstrom R, et al. A comprehensive worksite cancer prevention intervention: behavior change results from a randomized controlled trial (United States). Journal of Public Health Policy 2003;24(1):5‐25.

Sorensen 2007 {published data only}

Sorensen G, Barbeau EM. Integrating occupational health, safety and worksite health promotion: opportunities for research and practice. Medicina del Lavoro 2006;97(2):240‐57.
Sorensen G, Barbeau EM, Stoddard AM, Hunt MK, Goldman R, Smith A, et al. Tools for health: the efficacy of a tailored intervention targeted for construction laborers. Cancer Causes and Control 2007;18:51‐9. [DOI: 10.1007/s10552‐006‐0076‐9]

Sutton 1987 {published data only}

Sutton S, Hallett R. Randomised trial of brief individual treatment for smoking using nicotine gum in a workplace setting. American Journal of Public Health 1987;77:1210‐1211.

Sutton 1988a {published data only}

Hallet R, Sutton SR. Predicting participation and outcome in four workplace smoking intervention programs. Health Education Research 1987;2:257‐66.
Sutton S, Hallett R. Smoking intervention in the workplace using videotapes and nicotine chewing gum. Preventive Medicine 1988;17:48‐59.

Sutton 1988b {published data only}

Sutton S, Hallett R. Smoking intervention in the workplace using videotapes and nicotine chewing gum. Preventive Medicine 1988;17:48‐59.

Sutton 1988c {published data only}

Sutton S, Hallett R. Smoking intervention in the workplace using videotapes and nicotine chewing gum. Preventive Medicine 1988;17:48‐59.

Sutton 1988d {published data only}

Sutton S, Hallett R. Smoking intervention in the workplace using videotapes and nicotine chewing gum. Preventive Medicine 1988;17:48‐59.

Sutton 1988e {published data only}

Sutton S, Hallett R. Smoking intervention in the workplace using videotapes and nicotine chewing gum. Preventive Medicine 1988;17:48‐59.

Tanaka 2006 {published data only}

Okamura T, Tanaka T, Babazono A, Yoshita K, Chiba N, Takebayashi T, et al. The High‐risk and Population Strategy for Occupational Health Promotion (HIPOP‐OHP) study: study design and cardiovascular risk factors at the baseline survey. Journal of Human Hypertension 2004;18:475‐85.
Okamura T, Tanaka T, Takebayashi T, Nakagawa H, Yamato H, Yoshita K, et al. Methodlogical issues for a large‐scale intervention trial of lifestyle modification: interim assessment of the High‐Risk and Population Starategy for Occupational Health Promotion (HIPOP‐OHP) Study. Environmental Health and Preventive Medicine 2004;9:137‐43.
Tanaka H, Yamato H, Tanaka T, Kadowaki T, Okamura T, Nakamura M. Effectiveness of a low‐intensity intra‐worksite intervention on smoking cessation in Japanese employees: a three‐year intervention trial. Journal of Occupational Health 2006;48:175‐82.

Terazawa 2001 {published data only}

Terazawa T, Mamiya T, Masui S, Nakamura M. [The effect os smoking cessation counselling at health checkup] [in Japanese]. Sangyo Eiseigaku Zasshi 2001;43(6):207‐13.

Willemsen 1998 {published data only}

Willemsen M, de Vries H, van Breukelen G, Genders R. Long‐term effectiveness of two Dutch worksite smoking cessation programs. Health Education and Behavior 1998;25:418‐435.

Windsor 1988 {published data only}

Windsor RA, Lowe JB. Behavioral impact and cost analysis of a worksite self‐help smoking cessation program. Progress in Clinical and Biological Research 1989;293:231‐242.
Windsor RA, Lowe JB, Bartlett EE. The effectiveness of a worksite self‐help smoking cessation program: a randomized trial. Journal of Behavioural Medicine 1988;11:407‐421.

References to studies excluded from this review

Addley 2001 {published data only}

Addley K, McQuillan P, Ruddle M. Creating healthy workplaces in Northern Ireland: evaluation of a lifestyle and physical activity assessment programme. Occupational Medicine 2001;51(7):439‐449.

Armitage 2007 {published data only}

Armitage CJ. Efficacy of a brief worksite intervention to reduce smoking: the role of behavioral and implementation intentions. Journal of Occupational Health Psychology 2007;12(4):376‐90.

Baile 1991 {published data only}

Baile WF, Gibertini M, Ulschak F, Snow Antle S. Impact of a hospital smoking ban: changes in tobacco use and employee attitudes. Addictive Behaviors 1991;16:419‐426.

Barbeau 2006 {published data only}

Barbeau EM, Li Y, Calderon P, Hartman C, Quinn M, Markkanen P, et al. Results of a union‐based smoking cessation intervention for apprentice iron workers (United States). Cancer Causes and Control 2006;17(1):53‐61.

Bertera 1990 {published data only}

Bertera RL, Oehl LK, Telepchak JM. Self‐help versus group approaches to smoking cessation in the workplace: eighteen month follow‐up and cost analysis. Amercian Journal of Health Promotion 1990;4(3):187‐192.

Borland 1991b {published data only}

Borland R, Owen N, Hill D, Schofield P. Predicting attempts and sustained cessation of smoking after the introduction of workplace smoking bans. Health Psychology 1991;10(5):336‐342.

Borland 1995 {published data only}

Borland R, Owen N. Need to smoke in the context of workplace smoking bans. Preventive Medicine 1995;24:59‐60.

Brenner 1992 {published data only}

Brenner H, Mielck A. Smoking prohibition in the workplace and smoking cessation in the Federal Republic of Germany. Preventive Medicine 1992;21:252‐261.

Brenner 1994 {published data only}

Brenner H, Fleischle B. Smoking regulations at the workplace and smoking behaviour: a study from Southern Germany. Preventive Medicine 1994;23:230‐234.

Brigham 1994 {published data only}

Brigham J, Gross J, Stitzer ML, Felch LJ. Effects of a restricted worksite smoking policy on employees who smoke. American Journal of Public Health 1994;84(5):773‐778.

Broder 1993 {published data only}

Broder I, Pilger C, Corey P. Environment and well‐being before and following smoking ban in office buildings. Canadian Journal of Public Health 1993;84(4):254‐258.

Bunger 2003 {published data only}

Bunger J, Lanzerath I, Ruhnau P, Gorlitz A, Fischer C, Kott J, et al. [Company health plan: Evaluation of interventions for the reduction of cardiovascular risks] of cardiovascular risks Operational demand for health: Evaluation from interventions to the lowering of cardiovascular risks [Operational demand for health: Evaluation of interventions for the reduction of cardiovascular risks] [Betriebliche Gesundheitsforderung: Evaluation von Interventionen zur Senkung kardiovascularer Risiken [in German]]. Arbeitsmed. Sozialmed. Umweltmed 2003;8:421‐5.

Burling 1994 {published data only}

Burling TA, Seidner AL, Gaither DE. A computer‐directed program for smoking cessation treatment. Journal of Substance Abuse 1994;6:427‐431.

Busch 2005 {published data only}

Busch M. Comparison of two programmes to help apprentices of a large corporation stop smoking. Arbeitsmedizin Sozialmedizin Umweltmedizin 2005;40:70‐3.

Campbell 2000 {published data only}

Campbell MK, Tessaro I, DeVellis B, Benedict S, Kelsey K, Belton L, et al. Tailoring and targeting a worksite health promotion program to address multiple health behaviors among blue‐collar women. American Journal of Health Promotion 2000;14(5):306‐313.

Choi 2007 {unpublished data only}

Choi KS, Lee CH, Kim SY, Choi TS, Ryu SH. Effect of nicotine patches on craving in a workplace smoking cessation program. European Neuropsychopharmacology. 2007; Vol. 17:S561‐S562.

Conrad 1996 {published data only}

Conrad KM, Campbell RT, Edington D, Faust HS, Vilnius D. The worksite environment as a cue to smoking reduction. Research in Nursing and Health 1996;19(1):21‐31.

Cooreman 1997 {published data only}

Cooreman J, Mesbah H, Leynaert B, Segala C, Pretet S. Evaluation of the impact of a smoking ban in a large Paris hospital. Semaine des Hopitaux 1997;73:317‐323.

Cornfeld 2002 {published data only}

Cornfeld MJ, Schnoll RA, Tofani SH, Babb JS, Miller SM, Henigan‐Peel T, et al. Implementation of a comprehensive cancer control program at the worksite: year one summary report. Journal of Occupational and Environmental Medicine 2002;44:398‐406.

Daughton 1992 {published data only}

Daughton DM, Andrews CE, Orona CP, Patil KD, Rennard SI. Total indoor smoking ban and smoker behaviour. Preventive Medicine 1992;21:670‐676.

Dawley 1984 {published data only}

Dawley HH, Fleischer BJ, Dawley LT. Smoking cessation with hospital employees: an example of worksite smoking cessation. International Journal of the Addictions 1984;19(3):327‐334.

Dawley 1993 {published data only}

Dawley LT, Dawley HH, Glasgow RE, Rice J, Correa P. Worksite smoking control, discouragement, and cessation. International Journal of the Addictions 1993;28(8):719‐733.

Eisner 1998 {published data only}

Eisner MD, Smith AK, Blanc PD. Bartenders' respiratory health after establishment of smoke‐free bars and taverns. Journal of the American Medical Association 1998;280:1909‐1914.

Emont 1992 {published data only}

Emont SL, Cummings KM. Using a low‐cost, prize‐drawing incentive to improve recruitment rate at a work‐site smoking cessation clinic. Journal of Occupational Medicine 1992;34(8):771‐774.

Eriksen 2005 {published data only}

Eriksen W. Work factors and smoking cessation in nurses' aides: a prospective cohort study. BMC Public Health 2005;5:143.

Etter 1999 {published data only}

Etter J‐F, Ronchi A, Perneger TV. Short‐term impact of a university‐based smoke‐free campaign. Journal of Epidemiology and Community Health 1999;53:710‐715.

Farkas 1999 {published data only}

Farkas AJ, Gilpin EA, Distefan JM, Pierce JP. The effects of household and workplace smoking restrictions on quitting behaviours. Tobacco Control 1999;8:261‐265.

Farrelly 1999 {published data only}

Farrelly MC, Evans WN, Sfekas AE. The impact of workplace smoking bans: results from a national survey. Tobacco Control 1999;8:272‐277.

Fine 2004 {published data only}

Fine A, Ward M, Burr M, Tudor‐Smith C, Kingdon A. health promotion in small workplaces ‐ a feasibility study. Health Education Journal 2004;63:334‐46.

Glasgow 1997 {published data only}

Glasgow RE, Cummings KM, Hyland A. Relationship of worksite smoking policy to changes in employee tobacco use: findings from COMMIT. Community Intervention Trial for Smoking Cessation. Tobacco Control 1997;6(Supp 2):209‐216.

Gomel 1993b {published data only}

Gomel M, Oldenburg B, Lemon J, Owen N, Westbrook F. Pilot‐study of the effects of a workplace smoking ban on indexes of smoking, cigarette craving, stress and other health behaviors. Psychology and Health 1993;8:223‐229.

Gottlieb 1990a {published data only}

Gottlieb NH, Nelson A. A systematic effort to reduce smoking at the worksite. Health Education Quarterly 1990;17(1):99‐118.

Graham 2007 {published data only}

Graham AL, Cobb NK, Raymond L, Sill S, Young J. Effectiveness of an internet‐based worksite smoking cessation intervention at 12 months. Journal of Occupational and Environmental Medicine 2007;49(8):821‐8.

Gritz 1988 {published data only}

Gritz ER, Marcus AC, Berman BA, Read LL, Kanim LEA, Reeder SJ. Evaluation of a worksite self‐help smoking cessation program for registered nurses. American Journal of Health Promotion 1988;3(2):26‐35.

Hagimoto 2007 {published data only}

Hagimoto A, Masui S, Nakamura M, Bai Y, Oshima A. [Effects of skill level on individual behavioral counselling for smoking cessation] (Japanese). Nippon Koshu Eisei Zasshi ‐ Japanese Journal of Public Health 2007;54:486‐95.

Hailstone 2005 {published data only}

Hailstone S, Wyndham A, Mitchell E. Delivering smoking cessation information in the workplace using Quit Online. N.S.W. Public Health Bulletin 2005;16:18‐22.

He 1997 {published data only}

He D, Berg JE, Hostmark AT. Effects of acupuncture on smoking cessation or reduction for motivated smokers. Preventive Medicine 1997;26:208‐214.

Heloma 2001 {published data only}

Heloma A, Jaakkola MS, Kahkonen E, Reijula K. The short‐term impact of national smoke‐free workplace legislation on passive smoking and tobacco use. American Journal of Public Health 2001;91(9):1416‐8.

Helyer 1998 {published data only}

Helyer AJ, Brehm WT, Gentry NO, Pittman TA. Effectiveness of a worksite smoking cessation program in the military. Program evaluation. American Association of Occupational Health N Journal 1998;46(5):238‐245.

Hope 1999 {published data only}

Hope A, Kelleher C, O'Connor M. Lifestyle and cancer: the relative effects of a workplace health promotion program across gender and social class. American Journal of Health Promotion 1999;13(6):315‐318.

Hotta 2007 {published data only}

Hotta K, Kinumi K, Naito K, Kuroki K, Sakane H, Imai A, et al. An intensive group therapy programme for smoking cessation using nicotine patches and internet mailing support in a university setting. International Journal of Clinical Practice 2007;61(12):1997‐2001.

Hudzinski 1994 {published data only}

Hudzinski LG, Sirois PA. Changes in smoking behavior and body weight after implementation of a non smoking policy in the workplace. Southern Medical Journal 1994;87(3):322‐327.

Humerfelt 1998 {published data only}

Humerfelt S, Eide GE, Kvale G, Aaro LE, Gulsvik. Effectiveness of postal smoking cessation advice: a randomized controlled trial in young men with reduced FEV1 and asbestos exposure. European Respiratory Journal 1998;11:284‐290.

Hunt 2003a {published data only}

Hunt MK, Fagan P, Lederman R, Stoddard A, Frazier L, Girod K, et al. Feasibility of implementing intervention methods in an adolescent worksite tobacco control study. Tobacco Control 2003;12:40‐5.
Sorensen G, Fagan P, Hunt MK, Stoddard AM, Girod K, Eisenberg M, et al. Changing channels for tobacco control with youth: developing an intervention for working teens. Health Education Research 2004;19(3):250‐60.

Hunt 2003b {published data only}

Hunt MK, Stoddard AM, Barbeau E, Goldman R, Wallace L, Gutheil C, et al. Cancer prevention for working class, multiethnic populations through small businesses: the healthy directions study. Cancer Causes and Control 2003;14:749‐60.

Hutter 2006 {published data only}

Hutter HP, Moshammer H, Neuberger M. Smoking cessation at the workplace: 1 year success of short seminars. International Archives of Occupational and Environmental Health 2006;79(1):42‐8.

Izuno 1990 {published data only}

Izuno T, Yoshida K, Shimada N, Muto T. An epidemiological study of health behavior and health consciousness in smoking behavior modification. Japanese Journal of Public Health 1990;37:308‐314.

Jason 1990 {published data only}

Jason LA, Jayaraj S, Blitz CC, Michaels MH, Klett LE. Incentives and competition in a worksite smoking cessation intervention. American Journal of Public Health 1990;80(2):205‐206.

Kadowaki 2004 {published data only}

Kadowaki T, Okamura T, Funakoshi T, Okayama A, Kanda H, Miyamatsu N, et al. Effectiveness of annual interventions for smoking cessation in an occupational setting in Japan. Environmental Health and Preventive Medicine 2004;9:161‐4.

Kinne 1993 {published data only}

Kinne S, Kristal AR, White E, Hunt J. Worksite smoking policies: their population impact in Washington State. American Journal of Public Health 1993;83(7):1031‐1033.

Klesges 1986 {published data only}

Klesges RC, Vasey MM, Glasgow RE. A worksite smoking modification competition: potential for public health impact. American Journal of Public Health 1986;76(2):198‐200.

Koffman 1998 {published data only}

Koffman DM, Lee JW, Hopp JW, Emont SL. The impact of including incentives and competitions in a workplace smoking cessation program on quit rates. American Journal of Health Promotion 1998;13(2):105‐110.

Kunitsuka 2002 {published data only}

Kunitsuka K, Yamatsu K, Adachi Y. [A correspondence behavioral approach for 6 lifestyle's improvements in a workplace] (Japanese). Nippon Koshu Eisei Zasshi 2002;49(6):525‐534.

Longo 1996 {published data only}

Longo DR, Brownson RC, Johnson JC, Hewett JE, Kruse RL, Novotny TE, Logan RA. Hospital smoking bans and employee smoking behavior : results of a national survey. Journal of the American Medical Association 1996;275(16):1252‐1257.

Longo 2001 {published data only}

Longo DR, Johnson JC, Kruse RL, Brownson RC, Hewett JE. A prospective investigation of the impact of smoking bans on tobacco cessation and relapse. Tobacco Control 2001;10:267‐272.

Lowe 1987 {published data only}

Lowe JB, Windsor RA, Post KL. Effectiveness of impersonal versus interpersonal methods to recruit employees into a worksite quit smoking program. Addictive Behaviors 1987;12:281‐284.

Maheu 1989 {published data only}

Maheu MM, Gevirtz RN, Sallis JF, Schneider NG. Competition/cooperation in worksite smoking cessation using nicotine gum. Preventive Medicine 1989;18:867‐876.

Matson‐Koffman 1998 {published data only}

Matson‐Koffman D, Lee JW, Hopp JW, Emont SL. The impact of including incentives and competition in a workplace smoking cessation program on quit rates. American Journal of Health Promotion 1998;13(2):105‐111.

McMahon 2001 {published data only}

McMahon SD, King C, Mautz B, Jason LA, Rossi JS, Redding CA. Worksite interventions: a methodological exploration and pilot study promoting behavior change. Journal of Primary Prevention 2001;22(2):103‐119.

McMahon 2002 {published data only}

McMahon A, Kelleher CC, Helly G, Duffy E. Evaluation of a workplace cardiovascular health promotion programme in the Republic of Ireland. Health Promotion International 2002;17(4):297‐308.

Musich 2003 {published data only}

Musich S, McDonald T, Hirschland D, Edington DW. Examination of risk status transitions among active employees in a comprehensive worksite health promotion program. Journal of Occupational and Environmental Medicine 2003;45(4):393‐9.

Muto 1998 {published data only}

Muto T, Nakmura M, Oshima A. Evaluation of a smoking cessation program implemented in the workplace. Industrial Health 1998;36(4):369‐371.

Nepps 1984 {published data only}

Nepps MM. A minimal contact smoking cessation program at the worksite. Addictive Behaviors 1984;9:291‐294.

Nerín 2002 {published data only}

Nerín I, Guillén D, Más A, Nuviala JA, Hernandez MJ. [Evaluation of a workplace anti‐smoking program at a company with 640 employees] (Spanish). Archivos de Bronchoneumologia 2002;38:267‐71.

Nerín 2005 {published data only}

Nerín I, Crucelaegui A, Más A, Villalba JA, Guillén D, Gracia A. [Results of a comprehensive workplace program for the prevention and treatment of smoking addiction] (Spanish). Archivos de Bronconeumologia 2005;41(4):197‐201.

O'Connell 2006 {published data only}

O'Connell M, Comerford BP, Wall HK, Yanchou‐Njike V, Faridi Z, Katz DL. Impediment profiling for smoking cessation: application in the workplace. American Journal of Health Promotion 2006;21(2):97‐100.

Offord 1992 {published data only}

Offord KP, Hurt RD, Berge KG, Frusti DK, Schmidt L. Effects of the implementation of a smoke‐free policy in a media center. Chest 1992;102(5):1531‐1536.

Olive 1996 {published data only}

Olive KE, Ballard JA. Changes in employee smoking behavior after implementation of restrictive smoking policies. Southern Medical Journal 1996;89(7):699‐706.

Olsen 1990 {published data only}

Olsen GW, Shellenberger RJ, Lacey SE, Fishbeck WA, Bond GG. A smoking cessation incentive program for chemical employees: design and evaluation. American Journal of Preventive Medicine 1990;6(4):200‐207.

Olsen 1991 {published data only}

Olsen GW, Lacey SE, Sprafka JM, Arceneaux TG, Potts TA, Kravat BA, et al. A 5 year evaluation of a smoking incentive program for chemical employees. Preventive Medicine 1991;20:774‐784.

Ong 2005 {published data only}

Ong MK, Glantz SA. Free nicotine replacement therapy programs vs implementing smoke‐free workplaces: a cost‐effectiveness comparison. American Journal of Public Health 2005;95(6):969‐75.

Patten 1995 {published data only}

Patten CA, Gilpin E, Cavin SW, Pierce JP. Workplace smoking policy and changes in smoking behaviour in California: a suggested association. Tobacco Control 1995;4(1):36‐41.

Pegus 2002 {published data only}

Pegus C, Bazzarre TL, Brown JS, Menzin J. Effect of the Heart At Work program on awareness of risk factors, self‐efficacy, and health behaviors. Journal of Occupational and Environmental Medicine 2002;44:228‐36.

Prior 2005 {published data only}

Prior JO, van Melle G, Crisinel A, Burnand B, Cornuz J, Darioli R. Evaluation of a multicomponent worksite health promotion program for cardiovascular risk factors ‐ correcting for the regression towards the mean effect. Preventive Medicine 2005;40(3):259‐67.

Richmond 1985 {published data only}

Richmond RL, Webster IW. A smoking cessation programme for use in general practice. The Medical Journal of Australia 1985;142:190‐194.

Rosenstock 1986 {published data only}

Rosenstock IM, Stregachis A, Heany C. Evaluation of a smoking prohibition policy in a health maintenance organization. American Journal of Public Health 1986;76:1014‐1015.

Roto 1987 {published data only}

Roto P, Ojala A, Sundman K, Jokinen K, Peltomakl R. Nicotine gum and withdrawal from smoking. Suomen Laakarllehtl 1987;36:3445‐3448.

Ryan 2002 {published data only}

Ryan PJ, Forster NJD, Holder D. Evaluation of a worksite smoking‐cessation program. Journal of Occupational and Environmental Medicine2002; Vol. 44, issue 8:703‐704.

Schlegel 1983 {published data only}

Schlegel RP, Manske SR, Shannon ME. Evaluation of the Canadian Armed Forces smoking cessation program. Proceedings of Sch World Conference on Smoking and Health 1983;288:445‐452.

Scott 1986 {published data only}

Scott RR, Prue DM, Denier CA, King AC. Worksite smoking intervention with nursing professionals: Long‐ term outcome and relapse assessment. Journal of Consulting and Clinical Psychology 1986;54(6):809‐813.

Shipley 1988 {published data only}

Shipley RH, Orleans CT, Wilbur CS, Piserchia PV, McFadden DW. Effect of the Johnson & Johnson Live for Life program on employee smoking. Preventive Medicine 1988;17(1):25‐34.

Sloan 1990 {published data only}

Sloan RP, Dimberg L, Welkowitz LA, Kristiansen MA. Cessation and relapse in a workplace quit‐smoking contest. Preventive Medicine 1990;19:414‐423.

Sorensen 1991 {published data only}

Sorensen G, Rigotti N, Rosen A, Pinney J, Prible R. Effects of a worksite non‐smoking policy: evidence for increased cessation. American Journal of Public Health 1991;81(2):202‐204.

Stoddard 2005 {published data only}

Stoddard AM, Fagan P, Sorensen G, Hunt MK, Frazier L, Girod K. Reducing cigarette smoking among working adolescents: results from the SMART study. Cancer Causes and Control 2005;16:1159‐64.

Ullen 2002 {published data only}

Ullen H, Hoijer Y, Ainetdin T, Tillgren P. Focusing management in implementing a smoking ban in a university hospital in Sweden. European Journal of Cancer Prevention 2002;11:165‐70.

Waage 1997 {published data only}

Waage HP, Vatten LJ, Opedal E, Hilt B. Smoking intervention in subjects at risk of asbestos‐related lung cancer. American Journal of Industrial Medicine 1997;31:705 712.

Wakefield 1996 {published data only}

Wakefield M, Roberts L, Owen N. Trends in prevalence and acceptance of workplace smoking bans among indoor workers in South Australia. Tobacco Control 1996;5:205‐208.

Whitney 1994 {published data only}

Whitney E, Harris N. A progress report on an ongoing smoking cessation initiative as part of a major wellness program. Health Values 1994;18(1):84‐90.

Wilbur 1986 {published data only}

Wilbur CS, Hartwell TD, Piserchia PV. The Johnson & Johnson LIVE FOR LIFE program: Its organization and evaluation plan. In: Cataldo MF, Coates TJ editor(s). Health and Industry. New York: John Wiley & Sons, 1986:338‐50.

Willemsen 1995 {published data only}

Willemsen MC, de Vries H. Evaluation of a smoking cessation intervention for Dutch employees consisting of self help methods and a group programme. Tobacco Control 1995;4(4):351‐354.

Willemsen 1999 {published data only}

Willemsen MC, de Vries H, Oldenburg B, van Breukelen G. Impact of a comprehensive worksite smoking cessation programme on employees who do not take part in cessation activities. Psychology and Health 1999;14(5):887‐895.

Woodruff 1993 {published data only}

Woodruff TJ, Rosbrook B, Pierce J, Glantz SA. Lower levels of cigarette consumption found in smoke‐free workplaces in California. Archives of Internal Medicine 1993;153:1485‐1493.

Simpson 2000 {published data only}

Dobbins TA, Simpson JM, Oldenburg B. Who comes to a workplace health risk assessment?. International Journal of Behavioural Medicine 1998;5:323‐34.
Harris D, Vita P, Oldenburg B, Owen N. Socio‐behavioural and environmental approaches to worksite health promotion: the intervention of the Australian National Workplace Health Project. Health Promotion Journal of Australia 1999;9:49‐54.
Oldenburg B, Sallis JF, Harris D, Owen N. Checklist of Health promotion Environments at Worksites (CHEW): development and measurement characteristics. American Journal of Health Promotion 2002;16(5):288‐99.
Simpson JM, Oldenburg B, Owen N, Harris D, Dobbins T, Salmon A, et al. The Australian National Workplace Health Project: Design and baseline findings. Preventive Medicine 2000;31(3):249‐60.

Albertsen 2006

Albertsen K, Borg V, Oldenburg B. A systematic review of the impact of work environment on smoking cessation, relapse and amount smoked. Preventive Medicine 2006;43:291‐305.

Bibeau 1988

Bibeau DL, Mullen KD, McLeroy KR, Green LW, Foshee V. Evaluation of workplace smoking cessation programs: a critique. American Journal of Preventive Medicine 1988;4(2):87‐95.

Bland 1997

Bland JM, Kerry SM. Trials randomised in clusters. British Medical Journal 1997;315:600.

Brownson 2002

Brownson RC, Hopkins DP, Wakefield MA. Effects of smoking restrictions in the workplace. Annual Review of Public Health 2002;23:333‐348.

Cahill 2008

Cahill K, Perera R. Competitions and incentives for smoking cessation (Cochrane Review). Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD004307.pub3]

CDC 1997

Eriksen MP. Making your workplace smokefree. http://www.cdc.gov/tobacco/secondhand_smoke/00_pdfs/fullguide.pdf (accessed 14th July 2008). Centers for Disease Control, 1997.

Danaher 1980

Danaher BG. Smoking cessation programs in occupational settings. Public Health Reports 1980;95:149‐157.

Drummond 1997

Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 2nd Edition. Oxford: Oxford University Press, 1997.

Eriksen 1998

Eriksen MP, Gottlieb NH. A review of the health impact of smoking control at the workplace. American Journal of Health Promotion 1998;13(2):83‐104.

Fichtenberg 2002

Fichtenberg CM, Glantz SA. Effect of smoke‐free workplaces on smoking behaviour: systematic review. British Medical Journal 2002;325:188‐191.

Fielding 1991

Fielding JE. Smoking control at the workplace. Annual Review of Public Health 1991;12:209‐234.

Fisher 1990

Fisher KJ, Glasgow RE, Terborg JR. Work‐site smoking cessation: a meta‐analysis of long‐term quit rates from controlled studies. Journal of Occupational Medicine 1990;32:429‐439.

Gruman 1993

Gruman J, Lynn W. Worksite and community intervention for tobacco control. In: Orleans CT, Slade J editor(s). Nicotine addiction: principles and management. New York: Oxford University Press, 1993:396‐411.

Hallett 1986

Hallet R. Smoking intervention in the workplace: review and recommendations. Preventive Medicine 1986;15(3):213‐231.

Jamrozik 2005

Jamrozik K. Estimate of deaths among adults in the United Kingdom attributable to passive smoking. BMJ 2005;330(7495):812.

Janer 2002

Janer G, Sala M, Kogevinas M. Health promotion trials at worksites and risk factors for cancer. Scandinavian Journal of Work and Environmental Health 2002;28(3):141‐157.

Klesges 1988

Klesges RC, Cigrang JA. Worksite smoking cessation programs: clinical and methodological issues. Progress in Behavior Modification 1988;23:36‐61.

Lancaster 2005a

Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001292.pub2]

MMWR 2008

MMWR Weekly. State smoking restrictions for private sector worksites, restaurants and bars ‐‐ United States, 2004 and 2007. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5720a3.htm (accessed 27th May 2008)2008; Vol. 57, issue 20:549‐52.

NICE 2006

York Health Economics Consortium. A rapid review of the cost‐effectiveness of workplace policies for smoking cessation in England. http://www.nice.nhs.uk/nicemedia/pdf/SmokingCessationEconomicsNon‐NHSFullReview.pdf (accessed May 22nd 2008)2006.

NICE 2007

National Institute for Health and Clinical Excellence. Workplace health promotion: how to help employees to stop smoking. http://www.nice.org.uk/nicemedia/pdf/PHI005guidance.pdf (accessed 23rd May 2008)2007.

Orleans 1982

Orleans CS, Shipley RH. Worksite smoking cessation initiatives: review and recommendations. Addictive Behaviors 1982;7(1):1‐16.

Peersman 1998

Peersman G, Harden A, Oliver S. Effectiveness of health promotion interventions in the workplace: a review. London: Health Education Authority, 1998.

Smedslund 2004

Smedslund G, Fisher KJ, Boles SM, Lichtenstein E. The effectiveness of workplace smoking cessation programmes; a meta‐analysis of recent studies. Tobacco Control 2004;13(2):197‐204.

Warner 1996

Warner KE, Smith RJ, Smith DG, Fries BE. Health and economic implications of a worksite smoking cessation program ‐ a simulation analysis. Journal of Occupational Medicine 1996;38:981‐992.

Windsor 1984

Windsor RA, Bartlett EE. Employee self‐help smoking cessation programs: a review of the literature. Health Education Quarterly 1984;11(4):349‐359.

References to other published versions of this review

Moher 2003

Moher M, Hey K, Lancaster T. Workplace interventions for smoking cessation. Cochrane Database of Systematic Reviews 2003, Issue 2.

Moher 2005

Moher M, Hey K, Lancaster T. Workplace interventions for smoking cessation. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD003440.pub2]

Characteristics of studies

Characteristics of included studies [author‐defined order]

Glasgow 1984

Methods

Country:USA
Recruitment: telephone company employees
Design: RCT, no details of randomization method

Participants

36 employees and spouses (25 women and 11 men)
69% female. Av. age: 37
Smoked: average of 18 yrs and on average 30 cpd
Participation rate: not reported

Interventions

Group therapy
Three groups: 1. abrupt reduction 2. gradual reduction 3. gradual reduction with feedback
pre‐ and two post‐tests; 7 weekly meetings with goals of 50% reduction per week in abrupt group; 25% per week in gradual group; 25% per week with graphs of daily nicotine intake for gradual/feedback group.

Outcomes

Self report of smoking status and consumption at 6m, with CO validation and cigarette butt weight.

Type of intervention

1. Intensive behavioural: GROUPS

Notes

Analyses were conducted on non‐abstinent subjects at end of treatment, to assess reduction efficacy.
Outcomes included changes in nicotine content (brand smoked), amount of cigarette smoked, and number of cigarettes smoked.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Frank 1986

Methods

Country: USA
Recruitment: University of Missouri employees
Evaluation: determine the effects of various amounts of hypnosis and hypnosis plus behavioural sessions
Design: RCT, no details of randomization method

Participants

63 smokers
Female: 62%
Median education: 16 yrs
Median income: US$27,000
Participation rate: not reported

Interventions

In the initial study, 48 subjects of the total (N = 63) used, were assigned to one of three treatments:
1. four hypnotherapy (HYP) sessions + booster
2. 2 HYP sessions
3. 2 HYP + 2 behavioural sessions + booster.
A follow‐up group was later recruited composed of 15 subjects who received 4 HYP + booster with less time between sessions.

Outcomes

Self‐reported cessation at 3m and 6m, with saliva thiocyanate confirmation at 3m only.

Type of intervention

1. Intensive behavioural: GROUPS

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Klesges 1987

Methods

Country: USA
Recruitment: Employees from 4 worksites in Fargo, North Dakota and 4 in Eugene, Oregon
Design: Cluster (worksite) randomization but individuals the unit of analysis. Two (competition/nocompetition) by two (relapse prevention training/no relapse prevention training) factorial design

Participants

Participants: 136 smokers from 8 worksites. Site size ranged from 50 ‐ 380
Av. age: 38. av cpd: 28
Smoked: average 19 years
Participation rate: not reported ‐ estimated 28% across all sites

Interventions

Evaluates the incremental effectiveness of competition and relapse prevention training in the context of a multicomponent cessation programme
Multicomponent cognitive behavioural programme for 6 weekly sessions; within‐site competition with weekly feedback on a visible barometer and monetary prizes at programme completion and at 6m; relapse prevention booster sessions were held at 1m and 2m intervals following the programme.

Outcomes

Cessation at 6m
Validation: CO and saliva thiocyanate

Type of intervention

1. Intensive behavioural: GROUPS

Notes

The competition incentive was conducted within each intervention worksite, rather than between the worksites.
Other outcomes included relapse prevention, smoking reduction, nicotine levels (brands), % of cigarette smoked.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

DePaul 1987

Methods

Country: USA
Recruitment: Employees at 43 worksites, recruited prior to a 3w television smoking cessation programme.
Design: Cluster randomization by worksite, matched for size

Participants

233 smokers in 21 group discussion worksites, 192 in 22 non‐group work sites.
Groups led by trained employees
Participation rate: not reported

Interventions

All participants were given self‐help manuals by company co‐ordinators and instructed to view the televized segments
1. Twice weekly group meetings
2. Self help alone

Outcomes

Abstinence at 12m (multiple PP)
Partial validation by salivary cotinine or family/colleague report

Type of intervention

1. Intensive behavioural: GROUPS

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Omenn 1988

Methods

Country: USA
Recruitment: Single worksite (13,000 workers, 9 employers)
Randomization: by nurses at aid stations using randomized assignment lists generated by research centre, within preference for format.

Participants

159 smokers (av. age 43, 66% male, av.cpd 25) with preference for group programme or no preference.
243 smokers with a preference for self help randomized to 3 different S‐H programmes
Groups lead by instructors trained in both programmes.
Participation rate: 11%

Interventions

Group therapy preference:
1. Multiple Component programme. 3 sessions over 3w
2. Relapse Prevention programme. 6 sessions over 6w
3. Minimal Treatment programme. Self‐help materials only. American Cancer Society's 22 page 'Quitter's Guide' 7‐day plan.
S‐H preference:
Same 3 programmes, all in manual form, with no group meetings.

Outcomes

Abstinence at 12m (single PP)
Validation: saliva cotinine <= 35ng/ml

Type of intervention

1. Intensive behavioural: GROUPS

Notes

Group programmes were held away from worksite in non‐work hours.
50% random sample of continuing smokers supplied salivary samples

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

DePaul 1989

Methods

Country: USA
Recruitment: Employees at 38 worksites, recruited prior to a 3w television smoking cessation programme.
Design: Cluster randomization by worksite

Participants

419 smokers who participated in the worksite programmes, 206 Group, 213 No Group conditions.
Participation rate: not reported

Interventions

1. 6 x twice‐weekly group meetings to coincide with the 3w television series, then monthly meetings for a year. Abstinent smokers and 5 of their family and 5 co‐workers entered for a lottery at the final group meeting and 12m follow up.
2. Self‐help manuals only

Outcomes

Abstinence from end of programme to 24m
Validation by saliva cotinine and co‐worker or relative confirmation.

Type of intervention

1. Intensive behavioural: GROUPS

Notes

This study featured monthly booster sessions and monetary incentives for abstainers, as a development of the design of the first De Paul study

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Sorensen 1993

Methods

Country: USA
Setting: 8 worksites in Bloomington, Minnesota
Design: Cluster randomized trial.

Participants

Intervention worksites (I): 1885 workers,
Comparison sites (C): 1479 workers. 39% smoked at baseline in I and 31% in C worksites
Participation rate: 12% of smokers (range 8‐29% by site); 3.7% of nonsmokers participated in classes to assist quitters.

Interventions

The 3m intervention included consultation for employers on the adoption of a non‐smoking policy, training for nonsmokers to provide assistance to smokers attempting to quit, and cessation classes for smokers

Outcomes

Quit rate, self‐reported ( an attempt was made to collect saliva samples for analysis for cotinine). Baseline survey of all employees was conducted 9m before intervention, companies then randomized, then 3m intervention period, 1m and 6m after the completion of intervention.
Evaluation period: 6m

Type of intervention

1. Intensive behavioural: GROUPS

Notes

Analyses were by individuals for some outcomes, although randomization was by worksite.
The study area had been an intervention site for the Minnesota Heart Health Program, and outcomes may not be generalizable.
Other outcomes included nonsmokers' support for quit attempts, co‐worker requests not to smoke, co‐workers non‐smoking, number of quit attempts.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

DePaul 1994

Methods

Country: USA
Setting: 61 worksites
Design: Cluster randomization by worksite

Participants

844 smokers recruited; 289 Self Help (SH), 281 Incentives (I), 283 Group (G).
Av. age 38, Av cpd 21
72% female in SH, 58% female in I, 59% female in G
Participation rate: 58% in SH, 59% in I, 55% in G

Interventions

Worksite interventions timed to coincide with a mass media intervention consisting of a week‐long smoking cessation series on TV, and a complementary newspaper supplement.
SH: Self‐help manual (ALA Freedom from Smoking in 20 days)
I: Self‐help manual and incentive payment of US$1 for each day abstinent up to US$175
G: 6 group meetings over 3w followed by 14 booster meetings over 6m. Incentive payments. Handouts from same S‐H manual. Maintenance manual (ALA A Lifetime of Freedom from Smoking)

Outcomes

Sustained abstinence at 12m
Validation: CO < 9ppm. Saliva cotinine at 6m only

Type of intervention

1. Intensive behavioural: GROUPS

Notes

Discussion section includes some cost‐benefit analysis.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Razavi 1999

Methods

Country: Belgium
Recruitment: workplace volunteers in 32 companies
Design: Open‐label cessation phase, then RCT for relapse prevention, using random numbers and blinded list

Participants

344 quitters, abstinent for at least 1m at end of 3m X 7 cessation programme including group therapy and NRT.
38% female, av age 39.

Interventions

1. Relapse Prevention (RP). 10 sessions inc group discussion and role play led by professional counsellor
2. RP. 10 sessions of group discussion led by former smokers.
3. No RP

Outcomes

Abstinence for 9m from start of RP programme.
Validation by expired CO < 10ppm and urinary cotinine <= 317ug/ml.(Rates for CO and self report alone also reported; higher than for doubly validated rates)

Type of intervention

1. Intensive behavioural: GROUPS

Notes

All participants for this study had achieved abstinence after a 3m group and NRT programme. This is a relapse prevention study, rather than cessation.
Other outcomes include predictors of sustained abstinence, weight gain.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Shimizu 1999

Methods

Country: Japan
Setting: Omihachiman city office
Design: RCT

Participants

53 volunteer smokers

Interventions

1. Intervention group received intensive education (i.e. the effect of smoking on health, the beneficial aspects of quitting smoking, how to stop smoking and how to deal with the withdrawal symptoms) for 5m, group lectures (twice) and individual counselling (three times).
2. Control group had no special treatment for 1st 5m

Outcomes

Self‐reported and validated using expired air CO concentration.

Type of intervention

1. Intensive behavioural: GROUPS

Notes

Other outcomes included predictors of cessation success.
Data were derived from abstract only

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Schröter 2006

Methods

Country: Germany
Setting: 4 worksites
Design: RCT, sessions allocated randomly to standard behavioural (SB) or relapse prevention (RP) programmes

Participants

79 workers, mean age 40, 58% male, mean cpd 24, mean FTND score 5.

Interventions

6x90min sessions over 8 wks, group counselling + NRT if wanted. First 2 sessions same, then:

1. SB: psycho‐educational, self‐monitoring, environmental cue control, problem‐solving, behavioural control strategies, operant conditioning, social support.

2. RP: functional analysis of high‐risk situations, planning for them, coping strategies, self‐monitoring, noting triggers.

Outcomes

Self‐reported CA and PPA at 1m and 12m.

Type of intervention

1. Intensive behavioural: GROUPS

Notes

12m non‐responders were phoned for smoking status.
SB participants were given 'rescue' RP training when necessary, so separation of interventions not guaranteed.
New for 2008 update.

Gunes 2007

Methods

Country: Turkey
Setting: Textile factory in Malatya
Design: matched controlled study, followed up at 6m

Participants

200 workers (425 smokers completed baseline questionnaire); 100 in each group, matched on age, education, working periods and amount smoked. Intervention and control groups worked different shifts. All male workforce, mean age 29.3, 81.7% married, 44.5% attended high school. Prevalence 65.9% smokers, 6.8% ex‐smokers.

Interventions

3‐wk 7‐step programme, based on stages of change model, and ALA programme.

Outcomes

Primary outcome was movement through stages of change, but 6m cessation rate also reported. PPA self‐report, no verification.

Type of intervention

1. Intensive behavioural: GROUPS

Notes

Reported as no attrition or losses to follow up.
New for 2008 update.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

High risk

N/A

Kornitzer 1980

Methods

Country: Belgium
Setting: 30 factories
Design: Cluster‐randomized matched pair design RCT. Randomization method not described.

Participants

Participants: 16,230 men aged 40‐59 (83.7% of eligible men)

Interventions

1. Intervention: All screened for height, weight, cholesterol, smoking, BP, ECG, personality and psychological testing. Top 20% at risk counted as the 'high risk' group, who received 6‐monthly individual physician counselling. Complete cessation was encouraged, but pipes or cigars allowed if necessary. Advice booklet also supplied. All smokers of 5 or more cpd received written advice to quit.. Environmental components included anti‐smoking posters and a factory conference on dangers of tobacco.
2. Control: a 10% sample screened at baseline were followed up; the 20% of this sample with the highest risk score were also identified as the control 'high risk' subset, to be analyzed separately. The 'Design and Methodology' paper reports that all eligible men in the control factories all received an ECG, but this is not mentioned in later reports.

Outcomes

7‐day PP at 2 yrs follow up.
5% sample of intervention group (327 men) were tested, + all of the original high‐risk group (1268). The 10% random sample control subjects were reviewed after 2 yrs, including the 20% high risk subgroup (202 men). Self report only, without biochemical verification

Type of intervention

1. Intensive behavioural: INDIVIDUAL COUNSELLING

Notes

This trial was added to the 2005 update
This is the Belgian Heart Disease Prevention Project

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Cambien 1981

Methods

Country: France
Recruitment: Worksite volunteers in 160 sections of an administrative organization.
Design Cluster‐randomized controlled trial. Randomization method not described

Participants

3336 men aged 25‐35 at baseline. 424 classified as at high risk of coronary disease, 868 at low risk.
Mean cpd 8.9 intervention, 10.0 control

Interventions

1. High risk intervention subjects recalled at 6m, 12m, 24m, low risk at 12m, 24m. All intervention subjects measured blood sample, weight, BP, no. of cpd. Given tailored advice on diet, alcohol and smoking at each visit.
2. Controls received no counselling or measurement between baseline and follow up

Outcomes

Abstinence/reduction at 2 yrs.
At 2yrs 568 (86%) of intervention group returned, and 529 (84%) of control group.
Validation: Blood CO

Type of intervention

2. Intensive behavioural: INDIVIDUAL COUNSELLING

Notes

This trial was added to the 2005 update
95 intervention subjects lost to follow up were heavier smokers (+4.4 cpd) vs 100 control subects lost to follow up (+0.4 cpd).

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Li 1984

Methods

Country: USA
Setting: naval shipyard
Recruitment: Smokers identified at worksite screening (unselected)
Design: RCT, no details of method

Participants

871 male asbestos‐exposed smokers
Av cpd: 24‐26

Interventions

1.Advice from occupational physician; minimal warning, results of pulmonary function tests, leaflets
2. As group 1 plus behavioural counselling

Outcomes

Sustained abstinence at 11m
Validation: expired CO

Type of intervention

2. Intensive behavioural: INDIVIDUAL COUNSELLING

Notes

Other outcomes included stratification by lung function, reduction by continuing smokers, predictors of successful quitting and characteristics of smokers refusing to participate in the study.
Randomization ratio (method not explained) changed halfway through the study from 3:1 to 1:1.

The study found wide variation in implementation of the study procedure by physicians

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

High risk

C ‐ Inadequate

Gomel 1993a

Methods

Country: Australia
Setting: 28 Sydney ambulance stations
Design: Cluster‐randomized RCT. method of randomization not described.

Participants

431 participants (88%) in 28 stations. av age 32 yrs. 128 smokers, mean cpd 17.9.

Interventions

1. Health Risk Assessment (HRA): (10 stations, 40 smokers): Measurement of BMI, % body fat, BP, cholesterol, smoking status, aerobic capacity. Feedback given, with high risk people referred to family GP. This minimal 30 minute intervention was the control group.
2. Risk Factor Education (RFE): (8 stations, 28 smokers): Same measures as HRA, + advice through manual and videos in a 50 minute session.
3. Behavioural Counselling (BC): (6 stations, 30 smokers). Same as RFE group, + up to 6 counselling sessions (averaged 3) over 10w, + staged change manual.
4. Behavioural Counselling + Incentives (BCI): (4 stations, 30 smokers).
As RFE, + manual and goal‐setting and follow‐up counselling (average 2 hrs). Also lottery draw for A$40 voucher if interim targets achieved, and final prize of A$1000 for highest achieving station at 6m.

Outcomes

Baseline, 3, 6 and 12m assessments.
PP abstinence at 12m, validated by serum cotinine.

Type of intervention

2. Intensive behavioural: INDIVIDUAL COUNSELLING/ INCENTIVES

Notes

This trial was added to the 2005 update
Fewer stations and participants were allocated to the more intensive interventions (BC and BCI) because of cost. Some contamination between conditions reported.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Kadowaki 2000

Methods

Country: Japan
Setting single factory, 542 employees
Design: RCT, allocation by random number

Participants

263 male smokers
Av. age 34, av cpd 19

Interventions

1. Physician advice, CO feedback, cessation contract, self‐help materials. follow up over 5m. Smoking Cessation Marathon during month 4
2. Delayed intervention control

Outcomes

Abstinence for > 1m at 5m
(also 12m follow up but by then control group also treated)
Validation: CO < 9ppm, plus urine test at 12m

Type of intervention

2. Intensive behavioural: INDIVIDUAL COUNSELLING

Notes

All male smokers (62.9%) were entered compulsorily into the trial. Female smokers (3.4%) were not included.
Other outcomes included smoking reduction, willingness to quit and predictors of success.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Lang 2000

Methods

Country: France
Setting: Annual health check in one large gas and electric company
Design: Cluster randomization by site physician, physician as unit of analysis

Participants

28 site physicians covering 1269 smokers and 2614 nonsmokers
Av. age: 38, 82% male
Av cpd: 14

Interventions

1. Low intensity intervention: Physician advice 5‐10 mins incl. leaflets
2. High intensity: as 1. plus quit date, moral contract, follow‐up phone call, and 2nd visit

Outcomes

Abstinence (self‐reported) for at least 6m at 1 yr follow up
Validation: CO measurement in subgroup

Type of intervention

2. Intensive behavioural: INDIVIDUAL COUNSELLING

Notes

Other outcomes included BMI and depression score

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Terazawa 2001

Methods

Country: Japan
Setting: Occupational health clinic
Design: RCT; details of randomization not described

Participants

228 smokers, randomized to intervention (117) or control (111). Average age 39, av cpd 23; 50% had made previous quit attempts.

Interventions

Baseline questionnaire during routine health check up, with CO and urinary metabolites measured and reported back.
1. Intervention: Stage‐matched counselling (15‐20 mins) by trained nurses, + 4 follow‐up phone calls for those prepared to set a quit date.
2. Control: baseline questionnaire and usual care.

Outcomes

Continuous abstinence at 6m and 12m. Validated by CO ?

Type of intervention

2. Intensive behavioural: INDIVIDUAL COUNSELLING

Notes

This trial was added to the 2005 update
25 smokers in the intervention group set a quit date and received the follow‐up calls.
Data were derived from abstract only

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Tanaka 2006

Methods

Country: Japan
Setting: 12 companies (500‐1000 employees each)
Design: Matched pairs controlled study (randomization intended but not feasible).

Participants

Int/Cont: 1382/1736 current smokers, 94%/97.4% M, 92.9%/95.7% blue‐collar workers, 66.1%/61.5% smoke >20 cpd. Significant differences between groups on age, gender, occupation type, cpd, controlled for in analysis.
71.6%/73.2% in precontemplation; 35.1%/34.5% had made at least one previous quit attempt.

Interventions

Intervention: 1. Posters, newsletters, website, advertising the cessation campaign and stages of change model.
2. Worksite smoking cessation programme, conducted by worksite nurse using research team materials, giving (a) 5 brochures on stages of change, (b) 4 counselling sessions + NRT if requested, (c) award to winner among abstainers. 6‐wk programme, run 5 times over 36m.
3. Advice re secondhand smoke, and designation of smoking areas.
4. Regular site visits by member of research time.
Control: Standard annual health checks.
Participation rate was 9% across all sites.

Outcomes

Sustained 6m abstinence at 12m, 24m, 36m, not biochemically verified.
Movement through stages of change, cost‐benefit analysis.

Type of intervention

2. INDIVIDUAL COUNSELLING/ ENVIRONMENTAL/ INCENTIVES

Notes

New for 2008 update (previously an excluded study)

Sorensen 2007

Methods

Country: USA
Setting: Phone‐based and mailed info, targeted at members of LIUNA (construction workers union).
Design: RCT, no details given

Participants

674 workers (354 intervention and 320 control*) completed baseline survey, and 582 (188 smokers [= current or quit within last 6m]) at 6m follow up. 94% male, mean age 40, smoking prevalence I:45%, C:40%.

Interventions

3m programme to increase fruit & veg consumption and quit smoking.
Intervention: (i) Phone‐based counselling, up to 4 calls in 3m.
(ii) Mailed tailored feedback. (iii) 6 mailings of targeted info. (iv) NRT if requested.
Control: Nothing during programme, but all targeted written info at study end.

Outcomes

Self‐reported 7‐day PPA at 6m, no verification.
Increased fruit & veg consumption.

Type of intervention

2. Intensive behavioural: INDIVIDUAL COUNSELLING

Notes

Tools for Health programme; specifically targeted blue‐collar workers.
* data supplied by authors
New for 2008 update.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

'survey respondents agreeing to participate were randomly assigned to one of two conditions'

Jeffery 1988

Methods

Country: USA
Setting: faculty and staff of the University of Minnesota
Design: RCT

Participants

59 volunteer smokers. Av age 36.8, female 64.5%
Participation rate: 2%

Interventions

Self‐help manual; optional education/counselling; financial contracts of US$5 to US$25 bi‐weekly. One group aimed at cessation, the other at reduction or cessation.

Outcomes

Self‐reported cessation rate immediately post‐treatment and at 6m, biochemically validated at both points (CO, SCN)

Type of intervention

3. SELF‐HELP

Notes

15,000 staff members were approached to join the study. Of 137 smokers expressing an interest in the programme, only 59 actually signed up to it.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Sutton 1988a

Methods

Country: UK
Setting: Company A with occupational health program near London
Design: RCT: cessation motivation vs seat belt video groups

Participants

77 in videotape conditions (33 for smoking video, 44 for seatbelts video), 55 non‐participant smokers (no‐treatment control group).

Interventions

Trial was described to company as a 'health information programme', and was open to all employees, whether or not they smoked.
1. 25‐minute video 'Dying for a Fag' (DFF) plus a cessation booklet, the Heatth Education Council's 'The smoker's guide to non‐smoking'
2. 25‐minute video on seatbelt use, + a leaflet about seatbelts
3. Smokers who chose not to participate ‐ no videos or information

Outcomes

Self‐reported PP smoking cessation at 3m and 1yr with CO validation < 10 ppm

Type of intervention

3. SELF‐HELP

Notes

Although all 4 trials (a‐d) are of similar design, and are reported in a single paper, we have treated them here as four separate RCTs.
Cash incentives were offered at baseline and at 12m follow up to boost questionnaire response rates.
The authors also present a 4‐study pooled analysis, which failed to detect signficant differences in cessation rates.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Sutton 1988b

Methods

Country: UK
Setting: Company B with occupational health program near London
Design: RCT: cessation motivation vs cessation motivation plus confidence boosting vs. political aspects of tobacco video groups

Participants

150 in videotape conditions (46, 50 and 54 in the 3 groups), + 374 non‐participant smokers

Interventions

Trial was described to company as a 'smoking education programme', and was open only to smokers.
1. 25‐minute video 'Dying for a Fag' (DFF) plus a cessation booklet, the Heatth Education Council's 'The smoker's guide to non‐smoking'
2. DFF with additional sequence to boost the confidence of those making a quit attempt (DFF+C)
3. 'Licence to Kill', on the political aspects of smoking (LTK).
4. Smokers who chose not to participate ‐ no videos or information

Outcomes

Self‐reported PP smoking cessation at 3m and 1yr with CO validation < 10 ppm

Type of intervention

3. SELF‐HELP

Notes

Cash incentives were offered at baseline and at 12m follow up to boost questionnaire response rates.
The authors also present a 4 study pooled analysis, which failed to detect significant differences in cessation rates.
Although the cessation rates appear to be significantly better in this study than in the other 3, the authors point out that follow up was around New Year, when many people try and stop anyway, and may also have been influenced by the concurrent BBC series 'So you want to stop smoking'

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Sutton 1988c

Methods

Country: UK
Setting: Company C with occupational health program near London
Design: RCT : cessation motivation vs cessation motivation minus a gory sequence vs. advertising aspects of tobacco videotapes groups

Participants

197 in videotape conditions (56, 67 and 74 in the 3 groups) + 226 non‐participant smokers

Interventions

Trial was described to company as a 'smoking education programme', and was open only to smokers.
1. 25‐minute video 'Dying for a Fag' (DFF) plus a cessation booklet, the Heatth Education Council's 'The smoker's guide to non‐smoking'
2. DFF with graphic 'shock' sequence about diseased lungs edited out, to lower fear element (DFF‐G)
3. 'The Tobacco War', on the advertising aspects of smoking (TW).
4. Smokers who chose not to participate ‐ no videos or information

Outcomes

Self‐reported PP smoking cessation at 3m and 1yr with CO validation < 10 ppm

Type of intervention

3. SELF‐HELP

Notes

Cash incentives were offered at 12m follow up to boost questionnaire response rate.
There were no differences between the video and non‐participant groups in long‐term abstinence .
The authors also present a 4 study pooled analysis, which failed to detect signficant differences in cessation rates.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Sutton 1988d

Methods

Country: UK
Setting: Company D with occupational health program near London
Design: RCT: cessation motivation vs another cessation motivation vs. advertising aspects of tobacco videotapes groups

Participants

179 in videotape conditions (62, 59 and 58 in 3 groups) + 360 non‐participant smokers

Interventions

Trial was described to company as a 'smoking education programme', and was open only to smokers.
1. 25‐minute video 'Dying for a Fag' (DFF) plus a cessation booklet, the Heatth Education Council's 'The smoker's guide to non‐smoking'
2. "Smoker's Luck", on a continuing smoker suffering from advanced smoking‐related disease (SL)
3. 'The Tobacco War', on the advertising aspects of smoking (TW).
4. Smokers who chose not to participate ‐ no videos or information

Outcomes

Self‐reported PP smoking cessation at 3m and 1yr with CO validation < 10 ppm

Type of intervention

3. SELF‐HELP

Notes

There were no differences between the video and non‐participants groups in long term abstinence.
Cash incentives were offered at baseline and at 12‐month follow‐up to boost questionnaire response rates.
The authors also present a 4 study pooled analysis, which failed to detect signficant differences in cessation rates.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Burling 1989

Methods

Country: USA
Recruitment: Veterans Administration Medical Centre employee volunteers
Design: RCT, no details of randomization method

Participants

58 smokers
57% female, Av. age 44
All participants smoked for at least 6m (validated with CO measurement)
Participation rate: not reported

Interventions

1. American Cancer Society and ALA pamphlets about smoking, a telephone hotline, and a stop‐smoking contest which gave vouchers for a draw, for each day when expired CO < 8ppm.
2. As 1, plus use of a computer to enter data on smoking behaviour and to smoke a cigarette through a filter attached to the computer; this produced an individualized nicotine fading programme

Outcomes

Abstinence at 6m
Validation: CO < 8ppm

Type of intervention

3. SELF‐HELP

Notes

Participants in the computer group had lower self efficacy scores than the contest‐only group

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Burling 2000

Methods

Country: USA
Recruitment: Worksite volunteers
Design: RCT, no details of randomization method

Participants

87 smokers
36% female, Av. age 38, av. cigs/day 15
Participation rate: not reported

Interventions

1. The Last Draw, an internet‐based interactive programme to aid preparation, quitting and relapse prevention, plus FadeAid, an aid to nicotine fading
2. ALA Freedom from Smoking booklet, 2 manuals and an audio relaxation tape

Outcomes

Abstinence at 6m (7day PP)
Validation: CO

Type of intervention

3. SELF‐HELP

Notes

73% of Group 1 participants used the interactive programme, compared with 90% of the comparison group who used the ALA programme

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Campbell 2002

Methods

Country: USA
Recruitment: 10 small manufacturing companies in NC.
Design: Cluster RCT, no details of randomization

Participants

859 blue‐collar women at baseline (73% of eligible). 538 completed programme to 18m. 53% aged 40 or younger, 58% African American. Mean BMI 29. 30% I group, 22% C group smoked.

Interventions

1. Intervention: computer‐tailored 'magazine' with dietary, exercise, smoking advice, at baseline and 6m, plus social support at work from trained helpers in participants' chosen activity. N.B. No lay helpers offered smoking support.
2. Delayed intervention (control): One computer‐tailored 'magazine at 6m, no social support.

Outcomes

Abstinence at 18m: self‐reported, no biochemical validation.

Type of intervention

3. SELF‐HELP

Notes

This trial was added to the 2005 update
Natural (lay) helpers declined training in smoking cessation, so this arm of the intervention was not available to participants trying to quit

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Kornitzer 1987

Methods

Country: Belgium
Recruitment: industrial worksite primary care clinic
Design: RCT, no details of randomization method

Participants

199 adult male smokers (av cpd 24‐5)

Interventions

1. Nicotine gum (4 mg) for at least 3m
2. Nicotine gum (2 mg) for same time period.
Minimal physician support

Outcomes

PP abstinence at 12m
Validation: cotinine and carboxyhaemaglobin in a sub‐sample

Type of intervention

4. PHARMACOLOGICAL

Notes

Blinding was broken at 3m, and participants were free to choose their dosage of nicotine gum.
Results were stratified by Fagerstrom score.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

High risk

C ‐ Inadequate

Sutton 1987

Methods

Country: UK
Recruitment: Worksite primary care clinic in UK retail company (employees 3,253)
Design: RCT, no details of method

Participants

270 participants invited out of 334 who expressed an interest
Av age:34, 70% F
av cpd 15.5

Interventions

1. Nicotine gum (2 mg) at least 4 boxes, duration not stated. (172 people)
2. Non‐intervention control group (no placebo) of 64 continuing smokers
Low level of support

Outcomes

Sustained abstinence at 12m; Validation: expired CO

Type of intervention

4. PHARMACOLOGICAL

Notes

Slight contamination of intervention group, as 4 control group members were moved at their own request into the intervention group.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

High risk

C ‐ Inadequate

Sutton 1988e

Methods

Country: UK
Recruitment: Worksite primary care clinic (employees 3,253)
Design: RCT, no details of method

Participants

161 adult smokers who were still smoking after 3m of a videotape smoking cessation programme. Av cpd 15‐19

Interventions

1.Nicotine gum (2 mg) for up to 12w
2.Non‐intervention control group (no placebo).
Low level of support

Outcomes

Validated long‐term abstinence at 12m
Validation: expired CO

Type of intervention

4. PHARMACOLOGICAL

Notes

Participants are the non‐quitters at 3m from Sutton 1988d
5/82 control subjects asked for and received treatment. One was a long‐term abstainer, and is classed as a control group success.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

High risk

C ‐ Inadequate

Kornitzer 1995

Methods

Country: Belgium
Recruitment: Worksite
Design: RCT, computer‐generated list

Participants

374 volunteers
male and female, age > 20 yrs. No. of cigarettes: > 10 day for > 3 years

Interventions

1.Active patch and active gum (2mg as required)
2.Active patch and placebo gum
3.Placebo patch and placebo gum
High level of adjunct support.

Outcomes

Sustained abstinence at 12m
Validation: baseline salivary cotinine, and expired CO < 10 ppm at each follow up

Type of intervention

4. PHARMACOLOGICAL

Notes

Other outcomes included dermatological and systemic adverse effects, and time to relapse.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Rodriguez 2003

Methods

Country: Spain
Setting: 1 transport company (mostly bus drivers) and 2 electrical utility worksites (mostly clerical) in Bilbao.
Design: Open RCT, with randomization by sealed opaque envelopes and computer‐generated random lists

Participants

218 participants randomized to intervention (115) and control (103). All had physical check up, Fagerstrom NTQ, lab tests and ECG at baseline

Interventions

1. Intervention: 5‐8 mins structured individual counselling on smoking cessation at baseline by occupational physician, + further contacts at 2 days, 15 days and 3m. Grade I (Fagerstrom score < 5) counselling only. Grade II (Fagerstrom score 5‐7) 8 wks x14 mg nicotine patches. Grade III (Fagerstrom score > 7) 4 wks x 21 mg, 4wks x 14mg, 4wks x 7mg. Lower grade interventions could be upgraded if necessary. Participants kept records of progress, withdrawal symptoms, adverse events; weight and tobacco consumption were checked at specified intervals.
2. Control: minimal (30‐60 secs) sporadic unstructured advice, usually at annual medical check up

Outcomes

Continuous abstinence (7 day PP at each assessment) at 12m.
Validated at each assessment by expired CO <= 10ppm

Type of intervention

4. PHARMACOLOGICAL

Notes

This trial was added to the 2005 update
Secondary outcomes were: change in tobacco withdrawal symptoms, and weight changes.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Malott 1984

Methods

Country: USA
Setting: volunteers from telephone company (8) and a medical clinic (16)
Design: RCT, no details of randomization method

Participants

24 participants av age 34, had smoked for an average of 16 years, and av cpd 24.
Average score on the Fagerstrom NTQ 6.0
Participation rate: not reported

Interventions

Group therapy
1. controlled smoking
2. controlled smoking plus partner support

Outcomes

Self‐monitoring records, laboratory analyses of spent cigarette butts, and CO at 6m

Type of intervention

5. SOCIAL SUPPORT

Notes

Other outcomes included nicotine levels (brand smoked), smoking reduction, CO levels in continuing smokers and % of cigarette smoked.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Glasgow 1986

Methods

Country:USA
Recruitment: VA hospital, savings and loan association, and a health insurance agency employee volunteers
Design: RCT, no details of randomization procedure

Participants

29 adult cigarette smokers
69% female. Av. age 33.5
Average 25 cpd
Fagerstrom score 5.7, indicating moderate levels of tobacco dependence.
Participation rate: not reported

Interventions

1. Basic program (BP): subjects participated in 6 weekly group meetings‐ focused on making reductions in the no. of cpd and reductions in nicotine content. Midway through the programme subjects given the option of either complete cessation or reducing the percentage of each cigarette smoked.
2. BP and social support (SS): the same treatment as subjects in the BP group; in addition, each BP plus SS subject selected a partner who provided support and encouragement during non‐work hours.

Outcomes

Self reports, examination and weighing of saved cigarette. Butts and 2 biochemical measures of smoking exposure, CO and saliva thiocyanate.

Type of intervention

5. SOCIAL SUPPORT

Notes

Outcomes included changes in nicotine content (brand smoked), amount of cigarette smoked, and number of cigarettes smoked. The influence of social support, or lack of it, was also assessed.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Dawley 1991

Methods

Country: USA
Recruitment: worksite volunteers in 2 comparable oil refineries in Southern Louisiana
Design: RCT, no details of randomization method

Participants

30 smokers (14 at intervention site and 16 at comparison site)
76% male
Av. age: 39, av. cpd 21
Participation rate: not reported

Interventions

1. Intervention: comprehensive programme of smoking control, discouragement, cinnamon sticks as cigarette substitutes, and smoking cessation
2. Control: smoking cessation alone

Outcomes

Self‐reported smoking cessation with urinary cotinine validation

Type of intervention

6. ENVIRONMENTAL SUPPORT

Notes

Introduction includes lengthy discussion of economic and health costs of smoking

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Erfurt 1991

Methods

Country: USA
Setting: 4 General Motors worksites, Michigan
Design: Cluster randomization by worksite

Participants

Random sample of 400‐500 employees screened at baseline and followed up 3 yrs later.
Predominantly male, white, blue collar.
41‐45% smoked at baseline, but in the rescreened sample only 41% in site 3 and 36% in site 4 smoked at baseline

Interventions

Smoking, high blood pressure & obesity targetted.
1 worksite was allocated to each of 4 conditions:
1. Wellness screening; identify risks & referral
2. As 1. + media, programme sign‐up campaigns and classes
3. As 1. + media, program sign‐up campaigns, menu of interventions including guided self‐help, group or individual counselling + follow up
4. As 3 + follow‐up counselling + Plant Organization including peer support, aimed at reducing relapse.
All sites initiated no smoking areas during the period.

Outcomes

Self‐reported smoking status

Type of intervention

6. ENVIRONMENTAL SUPPORT

Notes

Quit rates were calculated by combining 1985 smokers and ex‐smokers (i.e. at risk of relapse)as the denominator. If the calculation is based only on current smokers at 1985 compared with 1988 quitters, the results do not reach statistical significance.
Reduced prevalence at all 4 sites coincided with the setting‐up of restrictive policies in each site.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Hymowitz 1991

Methods

Country: USA
Setting: 6 white‐collar worksites. No worksite had a formal no‐smoking policy or ongoing smoking cessation activities.
Design: Cluster randomized trial

Participants

6 worksites ranging in size from 950 to 3,300 employees. 25% smoking prevalence.
252 employees aged 21 and older participated, representing only a small portion of the total number of smokers at each worksite.
62% female. Av. age 42.3
>60% White

Interventions

1. Full programme (I): volunteers participated in a 5w training programme for quit‐smoking group leaders, and received additional training ,support, and how‐to manuals to carry out a protocol for health education and sitewide intervention activities, as well as for the implementation of worksite smoking policies.
2. Group‐only (C): volunteers participated in the training programme for group leaders, but did not carry out the protocols for health education and smoking policies

Outcomes

Self‐reported cessation at 12m
Validation: expired air CO

Type of intervention

6. ENVIRONMENTAL SUPPORT

Notes

Unit of randomization was worksite but unit of analysis was the individual.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Rand 1989

Methods

Country: USA
Recruitment: Smoking volunteers employed at Francis Scott Key Medical Center, Baltimore.
Design: RCT, no randomization detail

Participants

47 subjects who completed 5 days verified abstinence.

Interventions

1.Contingent payment for continued abstinence + frequent monitoring (n = 17)
2. Non‐contingent payment for abstinence + frequent monitoring (n = 16)
3. Non‐contingent payment, infrequent monitoring (n = 14)

Outcomes

Quit rate at 6m, confirmed by CO validation

Type of intervention

7. INCENTIVES

Notes

Subjects had received a minimal cessation programme, i.e. a 15‐minute talk and a booklet, with no skills training in cessation or relapse prevention.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Windsor 1988

Methods

Country: USA
Recruitment: University of Alabama employees volunteering for a quit smoking programme
Design: randomized trial, using sealed numbered envelopes containing computer‐generated assignment prior to baseline interview.

Participants

378 smokers
Av. age 37, av cpd 23‐27
Therapist: health visitor

Interventions

All groups received a 10 minute session of brief advice
1.+ S‐H manuals
2. +S‐H and another session of counselling (20‐30 mins) with skills training, buddy selection and a contract
3.as 1. With monetary awards for cessation
4.as 2 with monetary rewards for cessation

Outcomes

Abstinence at 1 yr (sustained at 6w, 6m & 1 yr)
Validation: saliva thiocyanate < 100 ng/ml at all follow ups

Type of intervention

6. ENVIRONMENTAL SUPPORT/ INCENTIVES

Notes

Other outcomes included some cost‐benefit analysis, including efficacy of incentives..

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Glasgow 1993

Methods

Country: USA
Recruitment: 19 worksites in Oregon.
Design: Cluster randomized RCT

Participants

Worksites from 140‐600 employees. Smoking prevalence of 21‐22%; Av age 40‐41. 63% female. 474 in Incentives (I) Group, 623 in No incentives (NI) Group

Interventions

Company steering groups ran the programmes
1. I Group members were paid US$10 for each verified abstinent month, up to 10m, + monthly and end‐of‐programme lotteries. There was also a buddy scheme, with cash prizes to helpers.
2. NI Group operated their normal company policy, which usually restricted but didn't ban smoking

Outcomes

Cessation rates at 12m and 2 yrs, verified by CO and salivary cotinine

Type of intervention

7. INCENTIVES

Notes

Analysis was at both worksite and individual level.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Hennrikus 2002

Methods

Country: USA
Setting: 24 worksites in and around St Paul. No overlap with the Healthy Worker Project.
Design: Randomized 2 x 3 factorial design, with smokers followed up at 12m and 24m.
85.5% responded to 12m survey, and 81.7% to 24m survey

Participants

2402 smokers on 24 sites, four sites randomized to each of the 6 conditions. There were significant differences in demographic characteristics between sites.
Smoking prevalence ranged from 10.7% to 37.2%

Interventions

The three programme formats were group counselling, telephone counselling or a choice of group or phone.
The programmes were then offered with and without incentives (=6).
The incentive site smokers received US$10 for signing up to a programme, and US$20 for near or full completion. They were also offered US$20 for 30 days cessation, and were then entered into a prize draw for a US$500 cash prize.

Outcomes

Rates of recruitment to the programmes, and 7‐day smoking PP at 12m and 24m follow up.
Validation was by self report, confirmed by family member or friend.
A sample of 188 quitters at 24m were asked to supply a saliva sample (128 complied).
Winners of the prize draw could only claim their prizes by verifying abstinence with salivary cotinine.

Type of intervention

7. INCENTIVES

Notes

This is the SUCCESS Project.
Significant differences between worksites meant that several covariates had to be controlled for in the analyses.
Other outcomes included comparing quit rates of registrants for the programmes with non‐registrants

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Shi 1992

Methods

Country:USA
Setting: 9 Pacific Gas and Electric worksites, allocated to 4 levels of intervention.
Design: Quasi‐experimental, random assignment of worksites. Sites were blinded to other intervention conditions. 

Participants

2887 workers across 9 sites at baseline HRA survey (69% of eligibles). At 2 yr follow up 1998 (48%) were surveyed. Cross‐sectional, not cohort surveys.
> 40% of participants were manual workers, 25‐31% clerical, 15‐21% managerial and 12‐16% technical staff.. 74‐79% male, > 70% aged 30‐49. 

Interventions

1. (3 sites, 1372 participants): HRA (height, weight, smoking, BP, cholesterol, HDL levels) at start and end of programme, + a bi‐monthly health newsletter (counts as control group).
2. (2 sites, 1083 participants): As 1, + health resources centre and free self‐care booklets.
3. (2 sites, 1016 participants) As 2, + behaviour change workshops and a divisional HealthWise social support team.
4. (2 sites, 693 participants): As 3, + case management programme for high‐risk participants (the 15% with the highest risk scores) and an environmental policy (space, smoking policies, incentives, health fairs) 

Outcomes

Smoking prevalence at 2 yr follow up in all four intervention groups. Self‐report 'current smoker' at HRA; no biochemical confirmation.

Type of intervention

8. COMPREHENSIVE

Notes

This trial was added to the 2005 update.
This is the HealthWise Stepped Intervention Study (HSIS). Level 4 sites were pre‐selected by PG&E management (non‐random) and were significantly smaller than the other levels, reflecting the expense of the Level 4 interventions 

Glasgow 1995

Methods

Country: USA
Setting: 26 worksites in Oregon
Design: Cluster randomized trial

Participants

26 heterogeneous worksites in Oregon with between 125 and 750 employees ‐ an average of 247.
Participation rate: at baseline, early intervention rate was 38% and delayed intervention 58%.
At 2 yr follow up, early intervention rate was 40% and delayed intervention was 57%

Interventions

Take Heart Project, focusing on diet and smoking
Early intervention (multifaceted programme consisting of employee steering committee and a menu approach to conducting key intervention activities tailored to each site) vs. delayed but similar intervention

Outcomes

Self‐reported smoking cessation

Type of intervention

8. COMPREHENSIVE

Notes

This is the Take Heart worksite wellness program. Other outcomes included dietary intake and cholesterol levels

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Sorensen 1996

Methods

Country: USA
Setting: 108 worksites in 16 US states
Design: Randomized matched‐pair trial, using cross‐sectional surveys at baseline and 2 yr follow up

Participants

108 worksites with over 28,000 employees ( 49 ‐ 1700 workers per site). Participation rate 72%, Av age 41, 77% male, 92% white.
Only 3 of the 4 study centres (84 sites) measured changes in smoking, as the 4th centre sites (Florida) had smoking bans already in place.

Interventions

Each workplace had an employee as co‐ordinator, and an employee advisory board.
1) Individual core interventions: Process included a kickoff event, interactive activities, posters and brochures, self assessments, self‐help materials, campaigns and contests, and direct education through classes and groups.
2) Environmental core interventions:
Consultation on smoking policy, changes in cafeteria and vending machine food, and additional nutritional education.
Control sites had results of employee survey, and in some cases an optional minimal intervention of posters and newsletters.

Outcomes

Self‐reported smoking cessation, without biochemical validation. 6m abstinence at follow up, smoking prevalence.

Type of intervention

8. COMPREHENSIVE

Notes

This is the Working Well Trial.
Randomization and analysis were both based on worksite.
Other outcomes were dietary fat reduction, fibre intake and fruit and vegetable consumption.
Some control sites had minimal interventions such as posters and brochures.

The Working Well trial generated a nested cohort study, the WellWorks Trial, which examined dietary and smoking changes stratified by job type at the Massachusets worksites.
See Sorensen 1998 reference.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Sorensen 1998

Methods

Country: USA
Setting: 24 mainly manufacturing worksites in Massachusets, randomized into 12 pairs, and all thought to be using known or suspected carcinogens.
Randomization was by worksite, but analysis was by individual. Analysis in this paper was cohort‐based

Participants

5914 (61%) of sampled employees responded at baseline, and 5406 (62%) at 2 yr follow up.
The cohort who responded to both surveys was 2658 employees.

Interventions

3 elements of intervention:
1) Joint worker‐management programme planning and implementation
2) Consultation by project staff with management on environmental changes, inc tobacco control policies, healthy foods, occupational hazard reduction
3) Health education programs targeting individual behaviours in the risk factor areas.

Outcomes

Self‐reported abstinence for 6m before final survey.
No biochemical validation

Type of intervention

8. COMPREHENSIVE

Notes

The WellWorks Study is a nested component of the Working Well trial, but, unlike that trial, attempted to integrate health promotion and health protection interventions, and is therefore assessed separately.
Other outcomes included fat, fibre and fruit and vegetable consumption, and differences between blue‐ and white‐collar workers in all outcomes.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Willemsen 1998

Methods

Country: Holland
Setting: 4 work sites (chemical, telecommunication, public transport and local government) and 4 other similar worksites
Design: cluster randomized trial

Participants

279 employees at intervention sites and 234 employees at comparison sites
Average age: 41 years
75% male

Interventions

1. Comprehensive program (self‐help manuals, group courses, a mass media campaign, smoking policies and a 2nd yr programme)
2. Minimal intervention (self‐help manuals only).

Outcomes

Self‐reported smoking cessation and saliva cotinine estimation

Type of intervention

8. COMPREHENSIVE

Notes

Analysis of light vs heavy smokers suggests greater efficacy among heavy smokers (P values not given).
Other outcomes included relapse rates, the effectiveness of a 2nd yr programme.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Emmons 1999

Methods

Country: USA
Setting: 26 worksites in RI and SE Mass (Brown University based).
Only 22 sites completed the trial.
Design: randomized matched pair, following a cohort over 3 yrs. Randomization process not described

Participants

22 worksites, and 2055 participants who completed all surveys. No demographic differences between intervention and control groups. Smoking prevalence 28% across both groups.

Interventions

1. Intervention sites: As with Working Well Trial (Sorensen 1996), but including physical activity; a combination of individual and environmental programmes, including space, showers, equipment and discounted membership of fitness facilities.
2. Control sites: Minimal care: Could offer 2 S‐H smoking cessation programmes and 1 each on nutrition and physical activity.

Outcomes

Self‐reported abstinence at 3 yrs for 6m prior to assessment, and 7‐day PP
No biochemical validation used.
Secondary outcome: movement through stages of change

Type of intervention

8. COMPREHENSIVE

Notes

This trial was added to the 2005 update
This is the Working Healthy Projected, nested within the Working Well trial

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Nilsson 2001

Methods

Country: Sweden
Recruitment: 4 public sector worksites (568 employees) in Helsinborg.
Design: RCT
Randomization: method of allocation not stated.

Participants

Of 128 at‐risk workers invited, 60/65 randomized to the intervention group attended for baseline assessment, and 53/63 from the control group.
Mean age was 49.7, 61% female.

Interventions

1. Intervention group received 16 group sessions a year, as well as individual counselling by a nurse. Sessions included lectures, discussions, video sessions and outdoor activities.
2. Control group received standard written and oral advice about cardiovascular risk factors at the start of the intervention, and nothing thereafter.

Outcomes

PP at 12m and 18m. No biochemical validation.

Type of intervention

8. COMPREHENSIVE

Notes

Smoking was only one of several risk factors targeted, including BMI, BP,heart rate, low‐density lipoprotein and cholesterol.
Group sessions were held in working hours but away from the worksites.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Sorensen 2002

Methods

Country: USA
Setting: 15 manufacturing sites, probably handling hazardous chemicals, in Massachusetts.
Design: RCT, randomized by worksite, but analysed by individual employee.

Participants

9019 employees (80%) across 15 sites. Mean workforce size 741 employees. Responders in the control groups were younger, more likely to be female, less educated, less likely to be white, and less likely to be hourly‐paid rather than salaried.

Interventions

1. Control [8 sites] had Health Promotion (HP) intervention, i.e. consultation to management on tobacco control policies, catering and cafeteria policies, and programmes aimed at individuals, including self assessment with feedback, self‐help activities, contests, demonstrations and displays, opportunities to try behaviours and goals, and group discussions.
2. Experimental Group [7 sites] (HP/OHS= health promotion with occupational health and safety) had the same elements as the Control sites, plus management recommendations to reduce occupational hazard exposure. For individuals, occupational health and safety training was added to the tobacco and nutritional elements of the control programme.

Outcomes

Quit rates (PP) at 6m, reported by cross‐sectional survey and for the smoking cohort.
Self report only, no biochemical validation

Type of intervention

8. COMPREHENSIVE

Notes

This is the Wellworks‐2 Trial, targeting particularly blue collar workers. Analyses were cross‐sectional and cohort
Other primary outcomes were nutrition and perceived exposure to occupational hazards.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

ALA: American Lung Association
av: average
BMI: body mass index
BP: blood pressure
CO: carbon monoxide
cpd: cigarettes per day
ETS: environmental tobacco smoke
FTND: Fagerström Test for Nicotine Dependence
h: hour
HDL: high density lipids
HRA: health risk assessment
inc: Including
I: intervention; C: control
m: month
NRT: nicotine replacement therapy
NTQ: nicotine tolerance questionnaire
PPA: point prevalence abstinence
ppm: parts per million
RCT: randomized controlled trial
S‐H: self help
vs: versus
w: week
yr: year (s)

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Addley 2001

Observational study, no control worksites. Smoking was one of a number of lifestyle changes surveyed over a three‐year period, by a follow‐up postal survey six months after assessment.

Armitage 2007

RCT for smoking reduction; 2m duration
New for 2008 update.

Baile 1991

Follow‐up only four months. Evaluated the impact of a hospital smoking ban with no report of cessation programmes.

Barbeau 2006

Pre/post study, no control group, assessment at 5m
New for 2008 update.

Bertera 1990

Non randomized. Evaluated the relative efficacy and cost‐effectiveness of a stop smoking clinic versus self‐help kit in the workplace

Borland 1991b

Examined predictors of smoking cessation attempts not cessation rates after the introduction of workplace smoking bans.

Borland 1995

One group post‐test only. Surveyed smokers two years after a total workplace ban.

Brenner 1992

Population‐based survey, to assess the effects of workplace smoking bans and cessation rates, expressed as a quit ratio

Brenner 1994

One group, post‐test only. Evaluated smoking regulations at the workplace and smoking behaviour in Southern Germany.

Brigham 1994

Follow‐up for only four weeks. Examined the effects of a restricted worksite smoking ploidy on employees who smoke.

Broder 1993

Pre‐ and post‐ban surveys on three buildings (137 workers), to assess air quality and physical symptoms of ETS. Prevalence was not a primary outcome, but was reported as unchanged between the two surveys

Bunger 2003

Description of a cardiovascular risk reduction intervention in a power plant; no control or comparison site

Burling 1994

Descriptive report of a computer‐directed programme for smoking cessation treatment. Previous reported outcome data from a minimal intervention and intensive stop smoking treatment are presented.

Busch 2005

Observational study of 2 German factory interventions.
New for 2008 update.

Campbell 2000

Cross‐sectional survey of 859 women in nine North Carolina worksites, to assess health behaviours, risks and desire to change behaviour. A population‐based survey, with no control group or intervention.

Choi 2007

6 wk RCT of patches for reducing craving.
New for 2008 update.

Conrad 1996

Non‐randomized. Evaluated exposure to a worksite health‐promoting environment as an aid to smoking cessation.

Cooreman 1997

Eight years had lapsed between surveys. Evaluated the impact of a smoking ban in a large Paris hospital

Cornfeld 2002

Large cohort study, not a controlled intervention trial

Daughton 1992

One group, no pre‐test . Evaluated the effect of a smoking ban with partially subsidised cessation programmes.

Dawley 1984

Non‐randomized. Evaluation of a smoking cessation treatment programme of ten one‐hour sessions.

Dawley 1993

Follow‐up for only four months. A programme of smoking control in one company versus a smoking cessation class in a second company.

Eisner 1998

Outcome not smoking cessation but bartenders' respiratory health. Evaluated the respiratory health of bartenders before and after legislative prohibition of smoking in all bars and taverns by the state of California.

Emont 1992

Outcome not smoking cessation. Evaluated the effectiveness of incentives as an aid to recruitment.

Eriksen 2005

Survey of Norwegian nurses' smoking
New for 2008 update.

Etter 1999

Follow‐up for only four months. Evaluated a short‐term impact of a University‐based smoke‐free campaign.

Farkas 1999

Non‐workplace for part of study. Evaluated the association of household and workplace smoking restrictions with quit attempts, six month cessation and light smoking.

Farrelly 1999

Cross‐sectional not pre‐post‐test. Estimated the impact of workplace smoking restrictions on the prevalence and intensity of smoking among all indoor workers.

Fine 2004

Comparison of of CHD risk factor interventions and musculo‐skeletal interventions in Welsh workplaces. Outcome was acceptability and feasibility in small workplace.
New for 2008 update.

Glasgow 1997

Data from a population‐based survey of adult smokers who completed surveys in 1988 and 1993, as part of the COMMIT trial.

Gomel 1993b

Follow‐up for only six weeks. Examined the short‐term effects of a workplace smoking ban on indices of smoking, cigarette craving, stress and other health behaviours in 24 employees.

Gottlieb 1990a

Non‐randomized. Three‐stage study included a baseline survey, an assessment of the effects of competition on recruitment to a self‐help cessation programme and examination of the outcome of the cessation programme.

Graham 2007

Observational study, no control group
New for 2008 update.

Gritz 1988

Non‐randomized. Evaluation of a self‐help smoking cessation programme for registered nurses.

Hagimoto 2007

Assessment of counsellors' skills and success rates in 6 Japanese worksites.
New for 2008 update.

Hailstone 2005

Evaluation, no control group.
New for 2008 update.

He 1997

Follow‐up for only three weeks. Examined the effects of acupuncture on smoking cessation or reduction for motivated smokers.

Heloma 2001

Nine Finnish worksites surveyed before and after legislation to restrict ETS; not a controlled trial

Helyer 1998

Non‐randomized. Evaluated the effectiveness of a worksite smoking cessation programme in the military.

Hope 1999

Non‐randomized study, with no control or comparison group, and short follow‐up (timing not stated). Surveyed five workplaces before and after a one‐year health promotion campaign, targeting multiple health behaviours, including smoking. Primarily interested in gender and social class differences

Hotta 2007

Evaluation study, no control group
New for 2008 update.

Hudzinski 1994

Outcome was daily cigarette consumption, cessation rate not reported. Study was designed to assess changes in employee health, particularly weight gain and CO levels, and smoking behaviour.

Humerfelt 1998

Community‐based, not workplace. Evaluated the effects of postal smoking cessation advice in smokers with asbestos exposure and /or reduced forced expiratory volume in one second.

Hunt 2003a

The SMART study; RCT, targeting employed adolescents rather than adults.

Hunt 2003b

Healthy Directions ‐ Small Businesses study; RCT, but smoking cessation was not the target intervention, and was offered in both intervention and control sites (=24).

Hutter 2006

Evaluation of Allen Carr programme; no control group
New for 2008 update.

Izuno 1990

Non‐randomized. Examined the factors critical to behaviour modification with respect to smoking cessation at worksites.

Jason 1990

Non randomized. A cessation programme with incentives and competition offered in one company, compared to a control company.

Kadowaki 2004

Ten‐year Japanese programme of annual small‐scale smoking cessation interventions; assessed at two months, but primary outcome was overall prevalence after ten years. Controlled trial, but not randomized.

Kinne 1993

Population‐based telephone survey of 1228 employed adults to assess impact of worksite smoking policies.

Klesges 1986

Non‐randomized. A smoking cessation programme offered in five companies, with and without competitions for participation and cessation.

Koffman 1998

Not a randomized study, as one of the three participating worksites refused to be randomized.

Kunitsuka 2002

Survey of post‐intervention multiple lifestyle changes, including number of cigarettes smoked. No control group used.

Longo 1996

Not pre‐post‐test evaluation but post‐ban quit ratio. Examined the impact of workplace smoking bans on smoking behaviour of employees.

Longo 2001

Not pre‐post‐test. Examined the long term impact of workplace smoking bans on employee smoking cessation and relapse.

Lowe 1987

Cessation was not an outcome of interest. Evaluated method of contact (phone vs letter) as an aid to recruitment.

Maheu 1989

Non‐randomized. Two worksites offered a multi‐component behavioural programme with nicotine gum. Additional competition in one site.

Matson‐Koffman 1998

Non‐randomized. Evaluated the effectiveness of a multi‐component smoking cessation programme supplemented by incentives and team competitions.

McMahon 2001

Small non‐randomized pilot study, based on stages of change model, to compare expert systems, group support and self‐help manuals.

McMahon 2002

Happy Heart at Work programme; 10‐yr evaluation, without a control group

Musich 2003

Survey of changes in risks among GM employees; not a controlled trial

Muto 1998

Non‐randomized. Evaluated the effectiveness of a smoking cessation programme known as 'Smoke Busters'.

Nepps 1984

Non‐randomized. Evaluation of a minimal contact smoking cessation programme at the worksite.

Nerín 2002

Evaluation of an anti‐smoking programme, without a comparison worksite

Nerín 2005

Evaluation study, no control group
New for 2008 update.

O'Connell 2006

Evaluation study, no control group
New for 2008 update

Offord 1992

One group, post‐test only. Evaluated the effect of a smoking ban, with no‐cost nicotine dependence treatment.

Olive 1996

One hospital had pre‐test data. Evaluated changes in employee smoking behaviour after implementation of restrictive smoking policies.

Olsen 1990

Non‐randomized. Evaluation of a smoking cessation incentive programme for Dow chemical employees in the USA.

Olsen 1991

Non‐randomized. A five‐year evaluation of a smoking cessation incentive programme for chemical employees.

Ong 2005

Cost‐effectiveness rather than efficacy evaluation.
New for 2008 update.

Patten 1995

Population‐based telephone survey of 1844 Californian adult indoor workers, to assess changes in smoking status and cigarette consumption, related to whether or not their workplace was smoke‐free, and for how long the ban had been in place..

Pegus 2002

The Heart At Work programme. Smoking prevalence was measured, but was not an intervention outcome

Prior 2005

Cohort study, no comparison worksite
New for 2008 update.

Richmond 1985

Non‐workplace setting. A smoking cessation programme for use in general practice

Rosenstock 1986

Post‐test only. Evaluated a non‐smoking policy in a health maintenance organization

Roto 1987

Non‐workplace setting for half of the participants. Evaluated nicotine gum and advice versus advice only for smoking cessation.

Ryan 2002

594 employees at a UK pharmaceutical company (GSK) attempted to quit with bupropion, and were followed up at six months. Not an RCT.

Schlegel 1983

Non‐randomized. Evaluation of 'BUTT OUT' , a quit smoking programme developed specifically for the Canadian Armed Forces.

Scott 1986

Non‐randomized. Nurses in different units offered cessation treatment or a waiting list control. 29 participants.

Shipley 1988

Non‐randomized. Determined the effect of a smoking cessation programme compared with health screening on employee smoking.

Sloan 1990

Non‐randomized. Evaluated cessation and relapse in a year‐long workplace quit‐smoking contest.

Sorensen 1991

One group post‐test only . Evaluated the impact of a restrictive smoking policy with free onsite smoking cessation classes.

Stoddard 2005

RCT of teenagers (aged 15‐17) working part‐time, many still in school.
New for 2008 update

Ullen 2002

Evaluation of a Swedish hospital smoking ban, but without a comparison worksite

Waage 1997

Non‐randomized. Smoking intervention based on risk communication in subjects at risk of asbestos‐related lung cancer.

Wakefield 1996

Did not report smoking cessation rate. Compared the reported prevalence and acceptance of bans on smoking among indoor workers in South Australia.

Whitney 1994

One group, post‐test only. Determined the impact of a smoking cessation programme using nicotine replacement therapy as part of a larger wellness programme.

Wilbur 1986

Comprehensive health promotion intervention, but not a randomized trial

Willemsen 1995

Non‐randomized. Evaluated a smoking cessation intervention for Dutch employees consisting of self‐help methods and a group programme.

Willemsen 1999

Non‐randomized. Examined the impact of a comprehensive worksite smoking cessation programme on employees who do not take part in cessation activities.

Woodruff 1993

Results of the 1990 California Tobacco Survey; 11704 working adults responded. Aim was to assess relationship of worksite policy (or its absence) to smoking status, controlling for demographic factors

Characteristics of ongoing studies [ordered by study ID]

Simpson 2000

Trial name or title

Australian National Workplace Health Project

Methods

Cluster‐randomized trial, 20 worksites, 2x2 factorial design

Participants

Employees in participating worksites. 2498 completed baseline survey, 2082 completed health risk appraisal

Interventions

Socio‐behavioural and environmental intervention, for physical activity, healthy eating, smoking and alcohol

Outcomes

Behaviour change at 1 and 2 yrs

Starting date

NK

Contact information

[email protected]

Notes

Included in 2005 update; no further info for 2008 update

Data and analyses

Open in table viewer
Comparison 1. Results of included studies

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Results of included studies Show forest plot

Other data

No numeric data

Analysis 1.1

Study

Baseline/follow‐up

Smoking outcome

Validated ?

Burling 1989

58 smokers, all given self‐help materials and support. Experimental group (29) also exposed to computerised nicotine fading.

No significant difference in quit rates. 3/29 in Group 1 vs 6/29 in Group 2.
(See also Cochrane Review 'Self‐help interventions for smoking cessation')

Validation (participation and abstinence) measured at CO>8ppm

Burling 2000

87 smokers, randomised to an interactive nicotine fading programme, or a conventional cessation programme.
73% of the experimental group used their programme, compared with 90% of the comparison group who used theirs

No significant difference in quit rates. 6/45 in Group 1.vs 5/42 in Group 2. There was more evidence of effect for those who used the programmes than for those that didn't.
(See also Cochrane Review 'Self‐help interventions for smoking cessation')

Cambien 1981

304 intervention smokers recalled at 2 yrs, and 306 control smokers. 195 participants lost to follow up, proportion of smokers not reported

21.4% of intervention smokers quit, vs 13.4% of control smokers. Point prevalence at 2 yrs, not a significant difference

Validation by blood CO levels

Campbell 2002

538 women in 9 worksites (4 exp, 5 control) completed all surveys (282 I, 256 C) to 18m.

No raw data given for smoking, but prevalence went down by around 3% in both groups. No significant differences, and no p values.

Self‐report on all outcomes, no biochemical validation

Dawley 1991

16 employees in the experimental company (comprehensive programme), and 14 in the comparison company (cessation‐only programme)

Comprehensive Group achieved 43% (7/16) quit rate at 5 months, while the Cessation‐only Group achieved 21% (3/14). P‐values not given, but numbers too small for significant difference.

Validation by urinary cotinine

DePaul 1987

425 smokers in 43 corporations, randomised to group support programmes or self‐help alone programmes
Attrition rate was 8% in both groups

6% vs 2% continuously abstinent (NS), 19% in both groups were abstinent at 12 months point prevalence.
Companies were the unit of analysis, similar results found using individual as unit of analysis.
(See also Cochrane Review 'Self‐help interventions for smoking cessation')

Partial validation by salivary cotinine, with family and colleague report

DePaul 1989

419 smokers in 38 worksites, randomised to experimental programme (206) and comparison programme (213). The attrition rate was 17% for Group worksites and 29% for Non Group worksite participants, so correcting the data for attrition would increase the apparent efficacy of the Group condition.

At the company level of analysis the 12 month point prevalence quit rates were Group 26% vs No Group 16% (p<0.06); continuous abstinence rates were 11% (Group) vs 3% (No Group) (p<0.05).
Reported rates were not based on Intention to Treat, but on participation in the programmes. Correcting for attrition would increase the efficacy of the Group programme.
At 24 months, 30% of the Group smokers were abstinent, comnpared with 19.5% of Non‐Group smokers (no p value).
(See also Cochrane Review 'Self‐help interventions for smoking cessation')

Partial validation by salivary cotinine, with family and colleague report

DePaul 1994

844 smokers in 61 worksites, randomised to Self‐help [SH] (289), Incentives [I] (281) or Group support [G] (283).
12 month attrition rates were 52.5% in SH, 47.2% in I, and 37.5% in G.

12 month quit rates for sustained abstinence were 5.1% (n=79) SH, 11% (n=91) I, 31.2% (n=109) G (p<0.01). An Intention to Treat analysis, taking account of attrition, would further favour the intervention groups.
(See also Cochrane Review 'Self‐help interventions for smoking cessation')

Validation by salivary cotinine at 6 months, and CO<9ppm at 12 months

Emmons 1999

2055 workers (28% smokers) completed all surveys from 22 worksites, and constituted the cohort.

At 3 yr final follow up, 8.0% of the intervention smokers had quit for 6m, and 8.1% of the control smokers. 25.6% and 21.8% respectively claimed 7‐day PP. Differences were non‐significant

Self‐report, with no biochemical validation

Erfurt 1991

Four sites were assessed at baseline; Site 1 had 1096 smokers (45%), Site 2 598 (44%), Site 3 844 (41%) and Site 4 834 (44%).
At 3 year follow‐up Site 4 had been significantly restructured.

Participation was affected by the intervention: 5% in Site 1, 9% in Site 2, 53% in Site 3 and 58% in Site 4.
Possible bias due to different baseline characteristics of people rescreened in site3 & 4 limit interpretation of follow‐up smoking prevalences: 41.6%, 40.6%, 36.1%, 31.0%
All sites had significant relative reductions in smoking: 7.8% (p<0.01), 10.6% (p<0.01), 11.7% (p<0.001), 13.2% (p<0.001).
Of those smoking in 1985 who were re‐screened in 1988, 17.1% at Site 1 had quit, 17.6% at Site 2, 20.3% at Site 3 and 18.9% at Site 4 (NS).

Self‐report only, not biochemically validated

Frank 1986

48 smokers initially randomised to three groups, with varying levels of hypnosis, booster and self‐management training. A 4th group (15 smokers) was later recruited, with Group 2 interventions applied more intensively.
Attrition rate of 6% across the initial 3 groups at end of treatment, 17% at 3 months and 25% at 6 month follow‐up.

No difference between the groups for smoking cessation 6 months after treatment, regardless of the frequency, length between sessions, or addition of behavioural methods. Quit rate was 20% for all groups, based on Intention to Treat.
Intensive intervention produced initially higher quit rates (60% at end of treatment), but this reverted to 20% by 6 months
(See also Cochrane Review 'Hypnotherapy for smoking cessation')

Salivary cotinine measured at 3 months, but self‐report only at 6 months

Glasgow 1984

36 employees, randomised to abrupt reduction (13), gradual reduction (12) and gradual reduction + feedback (11).
Attrition at 6 months was respectively 4, 0 and 1.

At 6 months up to one third in the gradual condition were abstinent compared to no subjects in the abrupt condition (NS).
Intention to Treat analysis showed that the gradual reduction programme was more successful than the abrupt reduction (p<0.05)

CO<10 ppm at 6 months, weighing of cigarette butts

Glasgow 1986

29 employees randomised to Basic Programme (13) or Basic Programme + Social Support (16).
Attrition 7% at end of treatment, and a further 7% at 6 months

Consistent with previous findings, supportive social interactions were not related to treatment outcome.3/13 in the Basic Programme had quit at 6 months, and 3/16 in the Basic + Social Support Group (NS).
(See also Cochrane review 'Enhancing partner support to improve smoking cessation').

Self report, weighing of cigarette butts, CO monitoring and salivary thiocyanate

Glasgow 1993

19 worksites, random allocation to Incentive programme (474 smokers) or No Incentive programme (623 smokers).
Attrition rates at 1 year were 19% (I) and 24% (no I), and at 2 years were 27% and 32% respectively

At 2 year follow‐up 49/344 (14%) were abstinent in the Incentives group, and 49/426 (12%) in the No incentives group (NS). Intention to Treat analysis would give more conservative quit rates

CO monitoring and salivary cotinine

Glasgow 1995

26 worksites, randomised to early or delayed interventions. 1222 employees were followed up at 2 years.

Comprehensive programme; a 26% rate of cessation was noted across both longitudinal cohort groups (NS), and a 30% rate across both cross‐sectional groups (NS). No significant differences were seen between the 2 types of intervention

Self report, not biochemically validated

Gomel 1993a

28 ambulance stations randomized to 4 levels of risk reduction intervention. 128 baseline smokers followed for 1 yr

No significant differences between HRA and RFE groups at any follow‐up point, nor between BC and BCI groups. HRA and RFE groups (68 smokers) were pooled and compared with 60 smokers in pooled BC and BCI groups. Continuous abstinence rates at 6m were 1% for HRA+RFE and 10% for BC+BCI (Fisher's Exact Test p=0.05); 12m rates were 0% and 7% (p=0.05).

Serum cotinine validation used.

Gunes 2007

200 smokers randomized to 7‐step behavioural programme or no intervention, followed for 6m

Hennrikus 2002

24 worksites, randomised to 6 programmes, 4 worksites in each programme. 2402 smokers were surveyed at baseline and at 12 and 24 months. 85.5% response rate at 12 months, and 81.7% at 24.

407 (17%) smokers signed up to programmes. 15.4% at 12 months and 19.4% at 24 months reported themselves as non‐smokers.
Recruitment was significantly higher in the incentive sites (22% vs 12% p=0.0054), but did not translate into higher cessation rates.
Quit rates were consistently higher among programme registrants than among non‐registrants, but the differential was greater in the non‐incentive sites (15%) than in the incentive ones (6.7%), consistent with incentives attracting smokers less motivated to quit.

Self‐report, validated by family member or friend.
A sample of quitters were asked to supply saliva, and were paid $25 if they complied.
Winners of cessation prize draws had to supply a valid saliva sample.

Hymowitz 1991

Six worksites randomised to Full Programme or Group‐only interventions. Participation was 50% in the Full Programme sites, and 44% at Group‐only (NS).
193/252 smokers who began the quit programme completed it.
Randomisation was by worksite, but analysis was by individual.

At 12 months, 23/131 (18%) in the Full Programme arm had quit, while 27/121 (22%) in the Group‐only arm had quit (NS).

Self‐report and expired CO<8 ppm.

Jeffery 1988

59 employees were randomly assigned to reduction (29) or cessation (30) groups, and surveyed at baseline and at 6 and 12 months. Attrition was 30% ‐ intention to treat analysis.

At 12 months 4/29 (14%) had quit in the reduction group, and 3/30 (10%) in the cessation group. No significant differences between the groups on either of the outcomes (dropout rate, cessation at 12 months).

self‐report confirmed by expired CO<8 ppm.

Kadowaki 2000

263 male employees randomised to intervention (132) or control (131).
No attrition, as inclusion was compulsory.

Quit rates 17/132 (Intervention), 4/131 (Control) at 5‐month follow‐up (p=0.003). Male smoking decreased from 62.9% to 56.7% (p=0.04).
Delayed intervention in the control group lead to 13% quit rate (16/123)

Expired CO<9 ppm at baseline, 5 months and 12 months, and a urine test at 12 months

Klesges 1987

136/480 smokers over 8 worksites; all received a behavioural programme, with the intervention sites also receiving a competition and prize component. Each group of sites (Intervention and Control) were also divided between relapse prevention training (2) and no relapse training (2).
Attrition rate was 7% at end of treatment, increased to 10% by 6 months follow‐up.

Competition intervention resulted in significantly higher quit rates at the end of the trial (39% vs 16%, p<0.004) but these differences decayed at 6 months (12% vs. 11%, NS ).

Using the baseline of 480 smokers who could have participated, 3% were abstinent at 6 months

Expired CO<10 ppm

Kornitzer 1980

30 Belgian factories (16,230 men) randomized to intervention (risk assessment, physician and written advice) or control (assessment only). tested at 2 yrs.

High risk intervention group (n=1268) reduced prevalence by 18.7% (84.5% to 68.7%), and high risk control group (n=202) reduced by 12.2% (80.8% to 70.9%). P < 0.05.
Random sample comparison: 5% of intervention group (n=327) reduced by 12.5%, compared with 10% control sample (n=800) reduced by 12.6% (ns).

Self report only, no biochemical validation.

Kornitzer 1987

199 employees were randomised to receive 2mg (101) or 4mg (98) nicotine gum.
Attrition at one year was 6% in the 2mg group and 7.2% in the 4mg group.

At 3 months 36% of the 2mg group and 45% of the 4mg group claimed to be abstinent. At that point,blinding was broken and individuals could choose their treatment group. Results were stratified by Fagerstrom score dependency. At 12 months, the 4mg group (90) had a 50% higher abstinence rate than the 2mg group (94) (p<0.05); this fails to reach significance if an intention‐to‐treat analysis is conducted. In the first 3 (blinded) months of trial, the heavier smokers benefited more from the higher dose gum.
After unblinding, 17% of the 4mg group continued treatment, whereas 39% of the 2mg group continued treatment. In the 4mg group 31% switched to 2mg, while 5% of the 2mg group switched to 4mg.

Baseline and 12 month cotinine blood samples (random sample of 69% at 12 months).

Kornitzer 1995

374 employees randomised to Group 1(149, active patch + active gum), Group 2(150, active patch + placebo gum) or Group 3(75, placebo patch + placebo gum)

At 12 months, abstinence in Group 1 was 18.1% (NS), in Group 2 12.7% (NS) and in Group 3 13.3% (NS). Time to relapse was significantly longer in Group 1 compared with the other 2 groups (p=0.04).

Salivary cotinine at baseline, and expired CO<10 ppm at subsequent checks

Lang 2000

30 worksite physicians (1095 smokers) were randomised to Group A (504, simple advice) or Group B (591, advice + support and 'contract').

2 physicians dropped out post randomisation.
3.4% of baseline non‐smokers in each group were smokers at 1 year follow‐up.
The sustained abstinence rate at 6 months or more (A: 4.6%; B: 6.1%) was non‐significant using the physician as the unit as analysis.
At 12 months, Group A had a quit rate of 13.5%, and Group B a rate of 18.4% (p=0.03)

Self‐report, with CO<7 ppm validation on a subset of 231 subjects whose physicians had access to a CO monitor.

Li 1984

871 employee smokers, randomised to Group 1 (simple warning) or Group 2(brief physician advice), stratified by normal/abnormal lung function.
After fine tuning, at 3 months 215 workers received counselling, while 361 received simple warning and 3 were excluded.
Attrition was 30%.

Counselled workers had an 8.4% abstinence rate at 11 months, compared with 3.6% in the control group (p<0.05).
Feedback on abnormal lung function was not significantly related to increased rates of quitting

Expired CO<10 ppm at 11 months follow‐up in all quitters, and in a random sample of 379 continuing smokers

Malott 1984

24 employees randomised to controlled smoking Group (1) or controlled smoking + partner support Group (2).
Attrition 4% at 6 months

Few differences were observed between controlled smoking and controlled smoking plus partner support conditions either during treatment or at the 6‐month follow‐up. 25% of Group 1, and 17% of Group 2 were abstinent at 6 months (NS).
(See Cochrane review 'Enhancing partner support to improve smoking cessation').

Self‐monitoring, butt counts, expired CO levels

Nilsson 2001

113 workers randomised to intervention (65) or control (63).
Attrition at 12 months was 32% for the intervention group, and 24% for the control group. At 18 months the respective attrition rates were 34% and 27%.

Baseline prevalence for both groups was 65%. At 12 months the intervention group point prevalence rate was 37%, and the control group 63%. At 18 months, the rates were 40% and 59% respectively. This difference influenced the decrease in mean risk score from 10.3 to 9.0 after 18 months in the intervention group (p=0.042)

Self‐report, not biochemically validated

Omenn 1988

402 employee smokers randomised within their preference for group or self‐help programmes, to 3 programmes, MCP (1), RPP (2) or MTP (3).
7% attrition rate at 12 months.

Self‐reported quit rates similar across all three group preference conditions but more missing saliva samples in self‐help so validated rates lower.
All self‐help programmes similar.
Results: Group 1 8/51, Group 2 10/57, Group 3 4/51 (NS)
SH1 7/76, SH2 9/82, SH3 6/85 (NS)

Salivary cotinine at 12 months <35 ng/ml

Rand 1989

47 employees randomised to contingent payment/frequent CO monitoring group (17), non‐contingent payment/frequent CO monitoring (16), non‐contingent payment/ infrequent monitoring (14).
4 participants failed to abstain for 5 days, and were excluded before randomisation.
At 6 months 11 more participants had dropped out. Analyses were Intention to Treat at randomisation.

Contingent payment combined with frequent CO monitoring delayed but did not ultimately prevent participant relapse to smoking by the end of the six month follow‐up. Contingent payment group had CO value at or less than 11 ppm significantly longer than the other two groups (p=0.03). CO monitoring alone had no effect on abstinence.
At six months, only 2 subjects ( 1contingent, 1 non‐contingent) had achieved sustained abstinence.

Expired CO monitoring <12 ppm

Razavi 1999

344 post‐cessation abstainers randomised to psychologist support (135), ex‐smoker support (88), or no formal support (121),

12 months abstinence rates were 59/135 (43.7%) in the PG group; 33/88 (37.5%) in the SG group; 43/121 (35.5%) in no support group (NS).

Expired CO and urinary cotinine. Unvalidated self‐report (higher) were also given.

Rodriguez 2003

218 smokers randomized to counselling + NRT (115) or minimal sporadic advice (103) in 3 Bilabao (Spain) worksites

12 months continuous abstinence rates were 23/114 (20.2%) for the intervention group, vs 9/103 (8.7%) in the control group (P = 0.025).
NNT was 9 people treated for 3mss to produce 1 quitter

Expired CO <+ 10 ppm

Schröter 2006

38 smokers assigned to standard behavioural (SB) programme, 41 to relapse prevention (RP) programme.
Assessed at 12m for continuous and PP abstinence

12m continuous abstinence rates were 8/38 (21.1%) for SB, and 5/41 (12.2%) for RP.

Self‐reported, no biochemical validation

Shi 1992

2887 workers (533 smokers) across 9 Californian sites, partially randomized to 4 intervention levels. No non‐intervention control group 

2 yr cross‐sectional survey of 1998 workers (250 smokers); Prevalence declined by 34% from 18% to 12% in Level 1 (p < 0.1); by 18% from 17% to 14% in Level 2 (p < 0.1); by 35% from 24% to 15% in level 3 (p < 0.01); by 44% from 14% to 8% in Level 4 (p < 0.01) 

Self‐reported PP at HRA, not biochemically validated 

Shimizu 1999

53 volunteer employee smokers, randomised to intervention and control groups.

After the 5 months of intervention, smoking cessation rate in the intervention group (19.2%) tended to be higher than that in the control group (7.4%), (NS).
Control group was given same programme after the 5 months for the intervention group. At six months after both groups were treated, overall cessation rate was 24.5%, and at one year was 13.2%.

Expired CO monitoring

Sorensen 1993

Eight worksites, randomised to intervention (1885 workers) or comparison (1479 workers).
At baseline, 9 months before intervention, 34% of respondents were current smokers (I:39%;C:31%)
Six‐month data were on only 7 of the 8 sites, because of ownership changes at the 8th. Six‐month survey was of all smokers then employed, = 66% of originally surveyed employees.
Analyses were by individual, while randomisation was by worksite.

Analysis of all smokers, not just participants.
At the 6‐month follow‐up, 12% of smokers in the intervention group reported quitting, compared with 8.8% in the control group (p<0.05), controlling for age, sex & occupation.

Self‐report only.
Baseline and follow‐up salivary cotinines obtained for 52% of baseline smokers. These data were not analysed.

Sorensen 1996

108 matched worksites (>28,000 workers), randomised to intervention or control conditions, though Florida center sites did not target smoking, leaving smoking outcomes available in only 84 worksites.

Worksite was the unit of allocation and analysis. Baseline smoking data were not reported in detail.
There was a difference of 1.53% (NS) in the 6‐month quit rates between intervention and control sites, and a reduction in prevalence from 24.5% to 21.2% (I), and from 25.8% to 21.8% (C), a difference between the 2 groups of 0.66% (NS).

Self‐reported, no biochemical validation

Sorensen 1998

Cohort analysis (2658 employees) of a randomised controlled study of 12 matched pairs of worksites.
Worksite was unit of allocation, but analysis was by individual.

PP abstinence for the 6 months prior to 2‐year follow‐up was 15% for intervention group and 9% for control group (p=0.123)
Blue‐collar cessation rates for the 2 groups were 18% (I) and 9% (C), while the white‐collar workers achieved higher rates in the control than in the intervention group; office worker rates were 2.5% (I) vs 5.1% (C), and professipnal/managerial rates were 14.2% (I) vs 18.6% (C).

Self‐reported, no biochemical validation

Sorensen 2002

Cross‐sectional analysis (9019 at baseline [80%] and 7327 [65%] ) at six months follow‐up, plus cohort analysis of 5156 employees who responded to both surveys (embedded cohort of 436 smokers).
Worksite was unit of allocation, but analysis was by individual.

At six months, point prevalence in the HP/OHS sites fell from 20.4% to 16.3%, and in the HP sites from 18.6% to 17%.
In the embedded cohort (825 smokers) at 6m, the HP/OHS quit rate was 11.3%, compared with the HP rate of 7.5% (OR=1.57, p=0.17). Within the cohort, blue‐collar quit rates more than doubled in the HP/OHS sites (11.8%) compared with the HP sites (5.9%, p=0.04)

Self‐reported, no biochemical validation

Sorensen 2007

Baseline participants 674 workers, (354 Int/ 320 Cont).
188 smokers (101 Int, 87 Cont) completed baseline and 6m surveys

7‐day self‐reported PPA at 6m: Int: 19/101 (19%), Cont: 7/87 (8%) (P=0.03).
ITT analysis Int: 19/125 , Cont: 7/106, P=0.04.

Self‐reported, no biochemical validation

Sutton 1987

270/334 interested smokers invited to nicotine gum cessation programme; the uninvited 64 represented a control group. 172 (64%) of invitees attended the 1st consultation, 163 the 2nd.
One‐year follow‐up rate was 99% (9% by phone).

12% (20/172) of those who attended the intervention course were abstinent at 12 months, compared with 1% (1/98) of those who did not accept the invitation, and 2% (1/64) of the control group; p values not given.

Expired CO<11 ppm

Sutton 1988a

Video programme (smoking, plus seat‐belt advice) was offered to all employees. 77 employees were randomised to DFF video (33) or seatbelt (44=control) videos.

Abstinence rates (DFF: 3%, SB [control] 0%) were not significantly different from each other at 12 months follow‐up, There was no significant difference in validated abstinence between the video groups and the non‐participant group.

Expired CO<11 ppm.

Sutton 1988b

150 employees (smokers only) participated. 46 watched the DFF video, 50 watched a confidence‐boosting version of the DFF video, and 54 (control group) watched LTK video.

Abstinence rates (DFF: 11%, DFF+C 8%, LTK [control] 9%) were higher than in the other 3 studies, but not significantly different from each other
at 12 months follow‐up. But there was a significant difference in abstinence rates between participant groups and the non‐participant group (4%, p<0.05).

Expired CO<11 ppm.

Sutton 1988c

197 employees (smokers only) participated. 56 watched the DFF video, 67 watched a less gory version of the DFF video, and 74 (control group) watched the TW video.
Non‐responder smokers at baseline had higher smoking prevalence (45%) than responders (29%), suggesting some response bias.

Abstinence rates (DFF: 4%, DFF‐G 3%, TW [control] 4%) were not significantly different from each other.
at 12 months follow‐up. There was no significant difference in abstinence rates between the video groups and the non‐participant group.

Expired CO<11 ppm.

Sutton 1988d

179 employees (smokers only) participated. 62 watched the DFF video, 59 watched SL video, and 58 (control group) watched TW video.
Non‐responder smokers at baseline had higher smoking prevalence (34%) than responders (22%), suggesting some response bias.

Abstinence rates (DFF: 3%, SL 2%, Tw [control] 5%) were not significantly different from each other at 12 months follow‐up. There was no significant difference in validated abstinence artes between the video groups and the non‐participant group.

Expired CO<11 ppm.

Sutton 1988e

Fourth study (D) of the video studies groups provided a nested RCT. 161 continuing smokers at 3‐month follow‐up were randomised to intervention (79) or control (82).
40.5% response rate, attending at least one consultation.

22% (7/32) of attenders in the intervention group were abstinent at 12 months, compared with 2% (1/47) of the non‐attending invitees, and compared with 2% (2/82)of the control group (p<0.001).
16% of intervention group achieved 'complete' sustained abstinence at 12 months, vs 2% control group (p<0.01).

Expired CO<11 ppm.

Tanaka 2006

Six intervention sites matched to 6 control sites; Of 1017 intervention smokers who completed baseline and 36m follow up, 125 participated in cessation campaign, and 79 accepted counselling + NRT.

6m sustained abstinence at 36m ITT analysis was 8.9% (123/1382) intervention vs 7.0% (121/1736) control. Quit rates in both groups rose steadily over 36m.

No biochemical confirmation

Terazawa 2001

228 smokers randomized to intervention (117) or control (111). 25 smokers in the intervention group made a supported quit attempt

PP 11.1% (13/117) in the intervention group at 12m, compared with 1.8% (2/111) controls. Continuous abstinence 6.8% (8/117) intervention, compared with 0.9% (1/111) controls. Fisher's Exact test 2‐tailed P = 0.04

Probably validated by expired CO

Willemsen 1998

Four intervention worksites matched to 4 control sites (minimal self‐help), giving 498 smokers who completed baseline survey and enrolled in programmes.

Overall sustained abstinence quit rates at 6 months were 8% (9% for heavy smokers) in the comprehensive group, and 7% (4% for heavy smokers) in the minimal group (no p values given)

Self‐report, plus baseline Fagerstrom score.
At 4‐month follow‐up, 'bogus pipeline' procedure was used, and at 14 months salivary cotinines were collected from 41/79 quitters

Windsor 1988

387 smokers randomly assigned to four groups, in a 2x2 factorial pre‐/post‐test design.
37 were lost to follow‐up, and were counted as continuing smokers

As monetary incentives made no difference, groups 1&3 were compared with 2&4. Sustained abstinence at 1 year was 5.8% (11/190) in the self‐help only groups, and 14.4% (27/188) in the self‐help + counselling groups (p<0.001).

Baseline salivary cotinine, and follow‐up salivas at 6 weeks, 6 months and 1 year.



Comparison 1 Results of included studies, Outcome 1 Results of included studies.

Open in table viewer
Comparison 2. Individual Treatments

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any behavioural therapy (various endpoints) Show forest plot

11

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 2.1

Comparison 2 Individual Treatments, Outcome 1 Any behavioural therapy (various endpoints).

Comparison 2 Individual Treatments, Outcome 1 Any behavioural therapy (various endpoints).

2 Individual Counselling (various endpoints) Show forest plot

8

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 2.2

Comparison 2 Individual Treatments, Outcome 2 Individual Counselling (various endpoints).

Comparison 2 Individual Treatments, Outcome 2 Individual Counselling (various endpoints).

3 Any self‐help intervention (various endpoints) Show forest plot

8

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 2.3

Comparison 2 Individual Treatments, Outcome 3 Any self‐help intervention (various endpoints).

Comparison 2 Individual Treatments, Outcome 3 Any self‐help intervention (various endpoints).

4 Pharmacological Treatments (various endpoints) Show forest plot

5

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 2.4

Comparison 2 Individual Treatments, Outcome 4 Pharmacological Treatments (various endpoints).

Comparison 2 Individual Treatments, Outcome 4 Pharmacological Treatments (various endpoints).

5 Social support Show forest plot

2

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 2.5

Comparison 2 Individual Treatments, Outcome 5 Social support.

Comparison 2 Individual Treatments, Outcome 5 Social support.

Open in table viewer
Comparison 3. Worksite Treatments

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Environmental support (various endpoints) Show forest plot

4

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 3.1

Comparison 3 Worksite Treatments, Outcome 1 Environmental support (various endpoints).

Comparison 3 Worksite Treatments, Outcome 1 Environmental support (various endpoints).

2 Incentives (various endpoints) Show forest plot

4

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 3.2

Comparison 3 Worksite Treatments, Outcome 2 Incentives (various endpoints).

Comparison 3 Worksite Treatments, Outcome 2 Incentives (various endpoints).

Study

Baseline/follow‐up

Smoking outcome

Validated ?

Burling 1989

58 smokers, all given self‐help materials and support. Experimental group (29) also exposed to computerised nicotine fading.

No significant difference in quit rates. 3/29 in Group 1 vs 6/29 in Group 2.
(See also Cochrane Review 'Self‐help interventions for smoking cessation')

Validation (participation and abstinence) measured at CO>8ppm

Burling 2000

87 smokers, randomised to an interactive nicotine fading programme, or a conventional cessation programme.
73% of the experimental group used their programme, compared with 90% of the comparison group who used theirs

No significant difference in quit rates. 6/45 in Group 1.vs 5/42 in Group 2. There was more evidence of effect for those who used the programmes than for those that didn't.
(See also Cochrane Review 'Self‐help interventions for smoking cessation')

Cambien 1981

304 intervention smokers recalled at 2 yrs, and 306 control smokers. 195 participants lost to follow up, proportion of smokers not reported

21.4% of intervention smokers quit, vs 13.4% of control smokers. Point prevalence at 2 yrs, not a significant difference

Validation by blood CO levels

Campbell 2002

538 women in 9 worksites (4 exp, 5 control) completed all surveys (282 I, 256 C) to 18m.

No raw data given for smoking, but prevalence went down by around 3% in both groups. No significant differences, and no p values.

Self‐report on all outcomes, no biochemical validation

Dawley 1991

16 employees in the experimental company (comprehensive programme), and 14 in the comparison company (cessation‐only programme)

Comprehensive Group achieved 43% (7/16) quit rate at 5 months, while the Cessation‐only Group achieved 21% (3/14). P‐values not given, but numbers too small for significant difference.

Validation by urinary cotinine

DePaul 1987

425 smokers in 43 corporations, randomised to group support programmes or self‐help alone programmes
Attrition rate was 8% in both groups

6% vs 2% continuously abstinent (NS), 19% in both groups were abstinent at 12 months point prevalence.
Companies were the unit of analysis, similar results found using individual as unit of analysis.
(See also Cochrane Review 'Self‐help interventions for smoking cessation')

Partial validation by salivary cotinine, with family and colleague report

DePaul 1989

419 smokers in 38 worksites, randomised to experimental programme (206) and comparison programme (213). The attrition rate was 17% for Group worksites and 29% for Non Group worksite participants, so correcting the data for attrition would increase the apparent efficacy of the Group condition.

At the company level of analysis the 12 month point prevalence quit rates were Group 26% vs No Group 16% (p<0.06); continuous abstinence rates were 11% (Group) vs 3% (No Group) (p<0.05).
Reported rates were not based on Intention to Treat, but on participation in the programmes. Correcting for attrition would increase the efficacy of the Group programme.
At 24 months, 30% of the Group smokers were abstinent, comnpared with 19.5% of Non‐Group smokers (no p value).
(See also Cochrane Review 'Self‐help interventions for smoking cessation')

Partial validation by salivary cotinine, with family and colleague report

DePaul 1994

844 smokers in 61 worksites, randomised to Self‐help [SH] (289), Incentives [I] (281) or Group support [G] (283).
12 month attrition rates were 52.5% in SH, 47.2% in I, and 37.5% in G.

12 month quit rates for sustained abstinence were 5.1% (n=79) SH, 11% (n=91) I, 31.2% (n=109) G (p<0.01). An Intention to Treat analysis, taking account of attrition, would further favour the intervention groups.
(See also Cochrane Review 'Self‐help interventions for smoking cessation')

Validation by salivary cotinine at 6 months, and CO<9ppm at 12 months

Emmons 1999

2055 workers (28% smokers) completed all surveys from 22 worksites, and constituted the cohort.

At 3 yr final follow up, 8.0% of the intervention smokers had quit for 6m, and 8.1% of the control smokers. 25.6% and 21.8% respectively claimed 7‐day PP. Differences were non‐significant

Self‐report, with no biochemical validation

Erfurt 1991

Four sites were assessed at baseline; Site 1 had 1096 smokers (45%), Site 2 598 (44%), Site 3 844 (41%) and Site 4 834 (44%).
At 3 year follow‐up Site 4 had been significantly restructured.

Participation was affected by the intervention: 5% in Site 1, 9% in Site 2, 53% in Site 3 and 58% in Site 4.
Possible bias due to different baseline characteristics of people rescreened in site3 & 4 limit interpretation of follow‐up smoking prevalences: 41.6%, 40.6%, 36.1%, 31.0%
All sites had significant relative reductions in smoking: 7.8% (p<0.01), 10.6% (p<0.01), 11.7% (p<0.001), 13.2% (p<0.001).
Of those smoking in 1985 who were re‐screened in 1988, 17.1% at Site 1 had quit, 17.6% at Site 2, 20.3% at Site 3 and 18.9% at Site 4 (NS).

Self‐report only, not biochemically validated

Frank 1986

48 smokers initially randomised to three groups, with varying levels of hypnosis, booster and self‐management training. A 4th group (15 smokers) was later recruited, with Group 2 interventions applied more intensively.
Attrition rate of 6% across the initial 3 groups at end of treatment, 17% at 3 months and 25% at 6 month follow‐up.

No difference between the groups for smoking cessation 6 months after treatment, regardless of the frequency, length between sessions, or addition of behavioural methods. Quit rate was 20% for all groups, based on Intention to Treat.
Intensive intervention produced initially higher quit rates (60% at end of treatment), but this reverted to 20% by 6 months
(See also Cochrane Review 'Hypnotherapy for smoking cessation')

Salivary cotinine measured at 3 months, but self‐report only at 6 months

Glasgow 1984

36 employees, randomised to abrupt reduction (13), gradual reduction (12) and gradual reduction + feedback (11).
Attrition at 6 months was respectively 4, 0 and 1.

At 6 months up to one third in the gradual condition were abstinent compared to no subjects in the abrupt condition (NS).
Intention to Treat analysis showed that the gradual reduction programme was more successful than the abrupt reduction (p<0.05)

CO<10 ppm at 6 months, weighing of cigarette butts

Glasgow 1986

29 employees randomised to Basic Programme (13) or Basic Programme + Social Support (16).
Attrition 7% at end of treatment, and a further 7% at 6 months

Consistent with previous findings, supportive social interactions were not related to treatment outcome.3/13 in the Basic Programme had quit at 6 months, and 3/16 in the Basic + Social Support Group (NS).
(See also Cochrane review 'Enhancing partner support to improve smoking cessation').

Self report, weighing of cigarette butts, CO monitoring and salivary thiocyanate

Glasgow 1993

19 worksites, random allocation to Incentive programme (474 smokers) or No Incentive programme (623 smokers).
Attrition rates at 1 year were 19% (I) and 24% (no I), and at 2 years were 27% and 32% respectively

At 2 year follow‐up 49/344 (14%) were abstinent in the Incentives group, and 49/426 (12%) in the No incentives group (NS). Intention to Treat analysis would give more conservative quit rates

CO monitoring and salivary cotinine

Glasgow 1995

26 worksites, randomised to early or delayed interventions. 1222 employees were followed up at 2 years.

Comprehensive programme; a 26% rate of cessation was noted across both longitudinal cohort groups (NS), and a 30% rate across both cross‐sectional groups (NS). No significant differences were seen between the 2 types of intervention

Self report, not biochemically validated

Gomel 1993a

28 ambulance stations randomized to 4 levels of risk reduction intervention. 128 baseline smokers followed for 1 yr

No significant differences between HRA and RFE groups at any follow‐up point, nor between BC and BCI groups. HRA and RFE groups (68 smokers) were pooled and compared with 60 smokers in pooled BC and BCI groups. Continuous abstinence rates at 6m were 1% for HRA+RFE and 10% for BC+BCI (Fisher's Exact Test p=0.05); 12m rates were 0% and 7% (p=0.05).

Serum cotinine validation used.

Gunes 2007

200 smokers randomized to 7‐step behavioural programme or no intervention, followed for 6m

Hennrikus 2002

24 worksites, randomised to 6 programmes, 4 worksites in each programme. 2402 smokers were surveyed at baseline and at 12 and 24 months. 85.5% response rate at 12 months, and 81.7% at 24.

407 (17%) smokers signed up to programmes. 15.4% at 12 months and 19.4% at 24 months reported themselves as non‐smokers.
Recruitment was significantly higher in the incentive sites (22% vs 12% p=0.0054), but did not translate into higher cessation rates.
Quit rates were consistently higher among programme registrants than among non‐registrants, but the differential was greater in the non‐incentive sites (15%) than in the incentive ones (6.7%), consistent with incentives attracting smokers less motivated to quit.

Self‐report, validated by family member or friend.
A sample of quitters were asked to supply saliva, and were paid $25 if they complied.
Winners of cessation prize draws had to supply a valid saliva sample.

Hymowitz 1991

Six worksites randomised to Full Programme or Group‐only interventions. Participation was 50% in the Full Programme sites, and 44% at Group‐only (NS).
193/252 smokers who began the quit programme completed it.
Randomisation was by worksite, but analysis was by individual.

At 12 months, 23/131 (18%) in the Full Programme arm had quit, while 27/121 (22%) in the Group‐only arm had quit (NS).

Self‐report and expired CO<8 ppm.

Jeffery 1988

59 employees were randomly assigned to reduction (29) or cessation (30) groups, and surveyed at baseline and at 6 and 12 months. Attrition was 30% ‐ intention to treat analysis.

At 12 months 4/29 (14%) had quit in the reduction group, and 3/30 (10%) in the cessation group. No significant differences between the groups on either of the outcomes (dropout rate, cessation at 12 months).

self‐report confirmed by expired CO<8 ppm.

Kadowaki 2000

263 male employees randomised to intervention (132) or control (131).
No attrition, as inclusion was compulsory.

Quit rates 17/132 (Intervention), 4/131 (Control) at 5‐month follow‐up (p=0.003). Male smoking decreased from 62.9% to 56.7% (p=0.04).
Delayed intervention in the control group lead to 13% quit rate (16/123)

Expired CO<9 ppm at baseline, 5 months and 12 months, and a urine test at 12 months

Klesges 1987

136/480 smokers over 8 worksites; all received a behavioural programme, with the intervention sites also receiving a competition and prize component. Each group of sites (Intervention and Control) were also divided between relapse prevention training (2) and no relapse training (2).
Attrition rate was 7% at end of treatment, increased to 10% by 6 months follow‐up.

Competition intervention resulted in significantly higher quit rates at the end of the trial (39% vs 16%, p<0.004) but these differences decayed at 6 months (12% vs. 11%, NS ).

Using the baseline of 480 smokers who could have participated, 3% were abstinent at 6 months

Expired CO<10 ppm

Kornitzer 1980

30 Belgian factories (16,230 men) randomized to intervention (risk assessment, physician and written advice) or control (assessment only). tested at 2 yrs.

High risk intervention group (n=1268) reduced prevalence by 18.7% (84.5% to 68.7%), and high risk control group (n=202) reduced by 12.2% (80.8% to 70.9%). P < 0.05.
Random sample comparison: 5% of intervention group (n=327) reduced by 12.5%, compared with 10% control sample (n=800) reduced by 12.6% (ns).

Self report only, no biochemical validation.

Kornitzer 1987

199 employees were randomised to receive 2mg (101) or 4mg (98) nicotine gum.
Attrition at one year was 6% in the 2mg group and 7.2% in the 4mg group.

At 3 months 36% of the 2mg group and 45% of the 4mg group claimed to be abstinent. At that point,blinding was broken and individuals could choose their treatment group. Results were stratified by Fagerstrom score dependency. At 12 months, the 4mg group (90) had a 50% higher abstinence rate than the 2mg group (94) (p<0.05); this fails to reach significance if an intention‐to‐treat analysis is conducted. In the first 3 (blinded) months of trial, the heavier smokers benefited more from the higher dose gum.
After unblinding, 17% of the 4mg group continued treatment, whereas 39% of the 2mg group continued treatment. In the 4mg group 31% switched to 2mg, while 5% of the 2mg group switched to 4mg.

Baseline and 12 month cotinine blood samples (random sample of 69% at 12 months).

Kornitzer 1995

374 employees randomised to Group 1(149, active patch + active gum), Group 2(150, active patch + placebo gum) or Group 3(75, placebo patch + placebo gum)

At 12 months, abstinence in Group 1 was 18.1% (NS), in Group 2 12.7% (NS) and in Group 3 13.3% (NS). Time to relapse was significantly longer in Group 1 compared with the other 2 groups (p=0.04).

Salivary cotinine at baseline, and expired CO<10 ppm at subsequent checks

Lang 2000

30 worksite physicians (1095 smokers) were randomised to Group A (504, simple advice) or Group B (591, advice + support and 'contract').

2 physicians dropped out post randomisation.
3.4% of baseline non‐smokers in each group were smokers at 1 year follow‐up.
The sustained abstinence rate at 6 months or more (A: 4.6%; B: 6.1%) was non‐significant using the physician as the unit as analysis.
At 12 months, Group A had a quit rate of 13.5%, and Group B a rate of 18.4% (p=0.03)

Self‐report, with CO<7 ppm validation on a subset of 231 subjects whose physicians had access to a CO monitor.

Li 1984

871 employee smokers, randomised to Group 1 (simple warning) or Group 2(brief physician advice), stratified by normal/abnormal lung function.
After fine tuning, at 3 months 215 workers received counselling, while 361 received simple warning and 3 were excluded.
Attrition was 30%.

Counselled workers had an 8.4% abstinence rate at 11 months, compared with 3.6% in the control group (p<0.05).
Feedback on abnormal lung function was not significantly related to increased rates of quitting

Expired CO<10 ppm at 11 months follow‐up in all quitters, and in a random sample of 379 continuing smokers

Malott 1984

24 employees randomised to controlled smoking Group (1) or controlled smoking + partner support Group (2).
Attrition 4% at 6 months

Few differences were observed between controlled smoking and controlled smoking plus partner support conditions either during treatment or at the 6‐month follow‐up. 25% of Group 1, and 17% of Group 2 were abstinent at 6 months (NS).
(See Cochrane review 'Enhancing partner support to improve smoking cessation').

Self‐monitoring, butt counts, expired CO levels

Nilsson 2001

113 workers randomised to intervention (65) or control (63).
Attrition at 12 months was 32% for the intervention group, and 24% for the control group. At 18 months the respective attrition rates were 34% and 27%.

Baseline prevalence for both groups was 65%. At 12 months the intervention group point prevalence rate was 37%, and the control group 63%. At 18 months, the rates were 40% and 59% respectively. This difference influenced the decrease in mean risk score from 10.3 to 9.0 after 18 months in the intervention group (p=0.042)

Self‐report, not biochemically validated

Omenn 1988

402 employee smokers randomised within their preference for group or self‐help programmes, to 3 programmes, MCP (1), RPP (2) or MTP (3).
7% attrition rate at 12 months.

Self‐reported quit rates similar across all three group preference conditions but more missing saliva samples in self‐help so validated rates lower.
All self‐help programmes similar.
Results: Group 1 8/51, Group 2 10/57, Group 3 4/51 (NS)
SH1 7/76, SH2 9/82, SH3 6/85 (NS)

Salivary cotinine at 12 months <35 ng/ml

Rand 1989

47 employees randomised to contingent payment/frequent CO monitoring group (17), non‐contingent payment/frequent CO monitoring (16), non‐contingent payment/ infrequent monitoring (14).
4 participants failed to abstain for 5 days, and were excluded before randomisation.
At 6 months 11 more participants had dropped out. Analyses were Intention to Treat at randomisation.

Contingent payment combined with frequent CO monitoring delayed but did not ultimately prevent participant relapse to smoking by the end of the six month follow‐up. Contingent payment group had CO value at or less than 11 ppm significantly longer than the other two groups (p=0.03). CO monitoring alone had no effect on abstinence.
At six months, only 2 subjects ( 1contingent, 1 non‐contingent) had achieved sustained abstinence.

Expired CO monitoring <12 ppm

Razavi 1999

344 post‐cessation abstainers randomised to psychologist support (135), ex‐smoker support (88), or no formal support (121),

12 months abstinence rates were 59/135 (43.7%) in the PG group; 33/88 (37.5%) in the SG group; 43/121 (35.5%) in no support group (NS).

Expired CO and urinary cotinine. Unvalidated self‐report (higher) were also given.

Rodriguez 2003

218 smokers randomized to counselling + NRT (115) or minimal sporadic advice (103) in 3 Bilabao (Spain) worksites

12 months continuous abstinence rates were 23/114 (20.2%) for the intervention group, vs 9/103 (8.7%) in the control group (P = 0.025).
NNT was 9 people treated for 3mss to produce 1 quitter

Expired CO <+ 10 ppm

Schröter 2006

38 smokers assigned to standard behavioural (SB) programme, 41 to relapse prevention (RP) programme.
Assessed at 12m for continuous and PP abstinence

12m continuous abstinence rates were 8/38 (21.1%) for SB, and 5/41 (12.2%) for RP.

Self‐reported, no biochemical validation

Shi 1992

2887 workers (533 smokers) across 9 Californian sites, partially randomized to 4 intervention levels. No non‐intervention control group 

2 yr cross‐sectional survey of 1998 workers (250 smokers); Prevalence declined by 34% from 18% to 12% in Level 1 (p < 0.1); by 18% from 17% to 14% in Level 2 (p < 0.1); by 35% from 24% to 15% in level 3 (p < 0.01); by 44% from 14% to 8% in Level 4 (p < 0.01) 

Self‐reported PP at HRA, not biochemically validated 

Shimizu 1999

53 volunteer employee smokers, randomised to intervention and control groups.

After the 5 months of intervention, smoking cessation rate in the intervention group (19.2%) tended to be higher than that in the control group (7.4%), (NS).
Control group was given same programme after the 5 months for the intervention group. At six months after both groups were treated, overall cessation rate was 24.5%, and at one year was 13.2%.

Expired CO monitoring

Sorensen 1993

Eight worksites, randomised to intervention (1885 workers) or comparison (1479 workers).
At baseline, 9 months before intervention, 34% of respondents were current smokers (I:39%;C:31%)
Six‐month data were on only 7 of the 8 sites, because of ownership changes at the 8th. Six‐month survey was of all smokers then employed, = 66% of originally surveyed employees.
Analyses were by individual, while randomisation was by worksite.

Analysis of all smokers, not just participants.
At the 6‐month follow‐up, 12% of smokers in the intervention group reported quitting, compared with 8.8% in the control group (p<0.05), controlling for age, sex & occupation.

Self‐report only.
Baseline and follow‐up salivary cotinines obtained for 52% of baseline smokers. These data were not analysed.

Sorensen 1996

108 matched worksites (>28,000 workers), randomised to intervention or control conditions, though Florida center sites did not target smoking, leaving smoking outcomes available in only 84 worksites.

Worksite was the unit of allocation and analysis. Baseline smoking data were not reported in detail.
There was a difference of 1.53% (NS) in the 6‐month quit rates between intervention and control sites, and a reduction in prevalence from 24.5% to 21.2% (I), and from 25.8% to 21.8% (C), a difference between the 2 groups of 0.66% (NS).

Self‐reported, no biochemical validation

Sorensen 1998

Cohort analysis (2658 employees) of a randomised controlled study of 12 matched pairs of worksites.
Worksite was unit of allocation, but analysis was by individual.

PP abstinence for the 6 months prior to 2‐year follow‐up was 15% for intervention group and 9% for control group (p=0.123)
Blue‐collar cessation rates for the 2 groups were 18% (I) and 9% (C), while the white‐collar workers achieved higher rates in the control than in the intervention group; office worker rates were 2.5% (I) vs 5.1% (C), and professipnal/managerial rates were 14.2% (I) vs 18.6% (C).

Self‐reported, no biochemical validation

Sorensen 2002

Cross‐sectional analysis (9019 at baseline [80%] and 7327 [65%] ) at six months follow‐up, plus cohort analysis of 5156 employees who responded to both surveys (embedded cohort of 436 smokers).
Worksite was unit of allocation, but analysis was by individual.

At six months, point prevalence in the HP/OHS sites fell from 20.4% to 16.3%, and in the HP sites from 18.6% to 17%.
In the embedded cohort (825 smokers) at 6m, the HP/OHS quit rate was 11.3%, compared with the HP rate of 7.5% (OR=1.57, p=0.17). Within the cohort, blue‐collar quit rates more than doubled in the HP/OHS sites (11.8%) compared with the HP sites (5.9%, p=0.04)

Self‐reported, no biochemical validation

Sorensen 2007

Baseline participants 674 workers, (354 Int/ 320 Cont).
188 smokers (101 Int, 87 Cont) completed baseline and 6m surveys

7‐day self‐reported PPA at 6m: Int: 19/101 (19%), Cont: 7/87 (8%) (P=0.03).
ITT analysis Int: 19/125 , Cont: 7/106, P=0.04.

Self‐reported, no biochemical validation

Sutton 1987

270/334 interested smokers invited to nicotine gum cessation programme; the uninvited 64 represented a control group. 172 (64%) of invitees attended the 1st consultation, 163 the 2nd.
One‐year follow‐up rate was 99% (9% by phone).

12% (20/172) of those who attended the intervention course were abstinent at 12 months, compared with 1% (1/98) of those who did not accept the invitation, and 2% (1/64) of the control group; p values not given.

Expired CO<11 ppm

Sutton 1988a

Video programme (smoking, plus seat‐belt advice) was offered to all employees. 77 employees were randomised to DFF video (33) or seatbelt (44=control) videos.

Abstinence rates (DFF: 3%, SB [control] 0%) were not significantly different from each other at 12 months follow‐up, There was no significant difference in validated abstinence between the video groups and the non‐participant group.

Expired CO<11 ppm.

Sutton 1988b

150 employees (smokers only) participated. 46 watched the DFF video, 50 watched a confidence‐boosting version of the DFF video, and 54 (control group) watched LTK video.

Abstinence rates (DFF: 11%, DFF+C 8%, LTK [control] 9%) were higher than in the other 3 studies, but not significantly different from each other
at 12 months follow‐up. But there was a significant difference in abstinence rates between participant groups and the non‐participant group (4%, p<0.05).

Expired CO<11 ppm.

Sutton 1988c

197 employees (smokers only) participated. 56 watched the DFF video, 67 watched a less gory version of the DFF video, and 74 (control group) watched the TW video.
Non‐responder smokers at baseline had higher smoking prevalence (45%) than responders (29%), suggesting some response bias.

Abstinence rates (DFF: 4%, DFF‐G 3%, TW [control] 4%) were not significantly different from each other.
at 12 months follow‐up. There was no significant difference in abstinence rates between the video groups and the non‐participant group.

Expired CO<11 ppm.

Sutton 1988d

179 employees (smokers only) participated. 62 watched the DFF video, 59 watched SL video, and 58 (control group) watched TW video.
Non‐responder smokers at baseline had higher smoking prevalence (34%) than responders (22%), suggesting some response bias.

Abstinence rates (DFF: 3%, SL 2%, Tw [control] 5%) were not significantly different from each other at 12 months follow‐up. There was no significant difference in validated abstinence artes between the video groups and the non‐participant group.

Expired CO<11 ppm.

Sutton 1988e

Fourth study (D) of the video studies groups provided a nested RCT. 161 continuing smokers at 3‐month follow‐up were randomised to intervention (79) or control (82).
40.5% response rate, attending at least one consultation.

22% (7/32) of attenders in the intervention group were abstinent at 12 months, compared with 2% (1/47) of the non‐attending invitees, and compared with 2% (2/82)of the control group (p<0.001).
16% of intervention group achieved 'complete' sustained abstinence at 12 months, vs 2% control group (p<0.01).

Expired CO<11 ppm.

Tanaka 2006

Six intervention sites matched to 6 control sites; Of 1017 intervention smokers who completed baseline and 36m follow up, 125 participated in cessation campaign, and 79 accepted counselling + NRT.

6m sustained abstinence at 36m ITT analysis was 8.9% (123/1382) intervention vs 7.0% (121/1736) control. Quit rates in both groups rose steadily over 36m.

No biochemical confirmation

Terazawa 2001

228 smokers randomized to intervention (117) or control (111). 25 smokers in the intervention group made a supported quit attempt

PP 11.1% (13/117) in the intervention group at 12m, compared with 1.8% (2/111) controls. Continuous abstinence 6.8% (8/117) intervention, compared with 0.9% (1/111) controls. Fisher's Exact test 2‐tailed P = 0.04

Probably validated by expired CO

Willemsen 1998

Four intervention worksites matched to 4 control sites (minimal self‐help), giving 498 smokers who completed baseline survey and enrolled in programmes.

Overall sustained abstinence quit rates at 6 months were 8% (9% for heavy smokers) in the comprehensive group, and 7% (4% for heavy smokers) in the minimal group (no p values given)

Self‐report, plus baseline Fagerstrom score.
At 4‐month follow‐up, 'bogus pipeline' procedure was used, and at 14 months salivary cotinines were collected from 41/79 quitters

Windsor 1988

387 smokers randomly assigned to four groups, in a 2x2 factorial pre‐/post‐test design.
37 were lost to follow‐up, and were counted as continuing smokers

As monetary incentives made no difference, groups 1&3 were compared with 2&4. Sustained abstinence at 1 year was 5.8% (11/190) in the self‐help only groups, and 14.4% (27/188) in the self‐help + counselling groups (p<0.001).

Baseline salivary cotinine, and follow‐up salivas at 6 weeks, 6 months and 1 year.

Figuras y tablas -
Analysis 1.1

Comparison 1 Results of included studies, Outcome 1 Results of included studies.

Comparison 2 Individual Treatments, Outcome 1 Any behavioural therapy (various endpoints).
Figuras y tablas -
Analysis 2.1

Comparison 2 Individual Treatments, Outcome 1 Any behavioural therapy (various endpoints).

Comparison 2 Individual Treatments, Outcome 2 Individual Counselling (various endpoints).
Figuras y tablas -
Analysis 2.2

Comparison 2 Individual Treatments, Outcome 2 Individual Counselling (various endpoints).

Comparison 2 Individual Treatments, Outcome 3 Any self‐help intervention (various endpoints).
Figuras y tablas -
Analysis 2.3

Comparison 2 Individual Treatments, Outcome 3 Any self‐help intervention (various endpoints).

Comparison 2 Individual Treatments, Outcome 4 Pharmacological Treatments (various endpoints).
Figuras y tablas -
Analysis 2.4

Comparison 2 Individual Treatments, Outcome 4 Pharmacological Treatments (various endpoints).

Comparison 2 Individual Treatments, Outcome 5 Social support.
Figuras y tablas -
Analysis 2.5

Comparison 2 Individual Treatments, Outcome 5 Social support.

Comparison 3 Worksite Treatments, Outcome 1 Environmental support (various endpoints).
Figuras y tablas -
Analysis 3.1

Comparison 3 Worksite Treatments, Outcome 1 Environmental support (various endpoints).

Comparison 3 Worksite Treatments, Outcome 2 Incentives (various endpoints).
Figuras y tablas -
Analysis 3.2

Comparison 3 Worksite Treatments, Outcome 2 Incentives (various endpoints).

Comparison 1. Results of included studies

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Results of included studies Show forest plot

Other data

No numeric data

Figuras y tablas -
Comparison 1. Results of included studies
Comparison 2. Individual Treatments

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any behavioural therapy (various endpoints) Show forest plot

11

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

2 Individual Counselling (various endpoints) Show forest plot

8

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

3 Any self‐help intervention (various endpoints) Show forest plot

8

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

4 Pharmacological Treatments (various endpoints) Show forest plot

5

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

5 Social support Show forest plot

2

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Figuras y tablas -
Comparison 2. Individual Treatments
Comparison 3. Worksite Treatments

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Environmental support (various endpoints) Show forest plot

4

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

2 Incentives (various endpoints) Show forest plot

4

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Figuras y tablas -
Comparison 3. Worksite Treatments